<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0510222689
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2022
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Zolgensma
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        ONASEMNOGENE ABEPARVOVEC
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        2000000000000
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        vg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Suspension for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        9
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Biological
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        Store in a refrigerator (2°C – 8°C), do not freeze
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        7984675.90
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Novartis Gene Therapies, Inc" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Novartis Gene Therapies, Inc
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 439]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Novartis Saudi Limited
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Novartis Europharm Limited
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M09AX
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Zolgensma is</strong></p><p>Zolgensma is a type of medicine called a &lsquo;gene therapy&rsquo;. It contains the active substance onasemnogene abeparvovec, which contains human genetic material.</p><p>&nbsp;</p><p><strong>What Zolgensma is used for</strong></p><p>Zolgensma is used to treat spinal muscular atrophy (SMA), a rare, serious inherited disease.</p><p>&nbsp;</p><p><strong>How Zolgensma works</strong></p><p>SMA occurs when there is a missing or abnormal version of a gene needed to make an essential protein called &lsquo;Survival Motor Neuron&rsquo; (SMN) protein. Lack of SMN protein causes nerves that control muscles (motor neurons) to die. This results in muscles becoming weak and wasting away, with eventual loss of movement.</p><p>&nbsp;</p><p>This medicine works by supplying a fully functioning copy of the SMN gene which then helps the body produce enough SMN protein. The gene is delivered into the cells where it is needed using a modified virus that does not cause disease in humans.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp;</p><p><strong>a.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>Do NOT use Zolgensma</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if your child is allergic to onasemnogene abeparvovec or any of the other ingredients of this medicine (listed in section&nbsp;6).</p><p>&nbsp;</p><p><strong>b.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>Take special care with Zolgensma</strong></p><p>Your child&rsquo;s doctor will check for antibodies before treatment to help decide if this medicine is suitable for your child.</p><p>&nbsp;</p><p><u>Liver problems</u></p><p>Talk to your child&rsquo;s doctor or nurse before this medicine is given if your child has had any liver problems. This medicine can lead to an increase in enzymes (proteins found within the body) produced by the liver or injury to the liver. Injury to the liver can lead to serious outcomes, including liver failure and death. Possible signs you need to look out for after your child is given this medicine include vomiting, jaundice (yellowing of the skin or of the whites of the eyes), or reduced alertness (see section&nbsp;4 for more information). Tell your child&rsquo;s doctor straightaway if you notice your child develops any symptoms suggestive of injury to the liver.</p><p>Your child will have a blood test to check how well the liver is working before starting treatment with Zolgensma. Your child will also have regular blood tests for at least 3&nbsp;months after treatment to monitor for increases in liver enzymes.</p><p>&nbsp;</p><p><u>Infection</u></p><p>An infection (e.g. cold, flu or bronchiolitis) before or after Zolgensma treatment may lead to more serious complications. Caregivers and close contacts with the patient should follow infection prevention practices (e.g. hand hygiene, coughing/sneezing etiquette, limiting potential contacts). You need to look out for signs of an infection such as coughing, wheezing, sneezing, runny nose, sore throat or fever. Tell your child&rsquo;s doctor straightaway if you notice your child develops any symptoms suggestive of infection <strong>before</strong> or <strong>after</strong> Zolgensma treatment.</p><p><u>Regular blood tests</u></p><p>This medicine can lower blood-platelet counts (thrombocytopenia). You need to look out for possible signs of a low blood-platelet count after your child is given Zolgensma such as abnormal bruising or bleeding (see section&nbsp;4 for more information).Most of the reported cases of a low blood-platelet count occurred within the first three weeks after the child was given Zolgensma.</p><p>Zolgensma can raise levels of a heart protein called troponin-I that may indicate injury to the heart. You need to look out for possible signs of heart problems after your child is given this medicine, such as pale grey or blue skin colour, difficulty in breathing, swelling of the arms and legs or of the belly (see section&nbsp;4 for more information).</p><p>Before starting treatment with Zolgensma, your child will have a blood test to check the amount of blood cells (including red blood cells and platelets), as well as troponin-I level in their body. They will also have a blood test to check their creatinine level, which is an indicator of how the kidneys are working. Your child will also have regular blood tests for a period of time after treatment to monitor for changes in platelets and troponin-I levels.</p><p>&nbsp;</p><p><u>Abnormal clotting of blood in small blood vessels (thrombotic microangiopathy)</u></p><p>There have been reports of patients developing thrombotic microangiopathy generally within the first two weeks after Zolgensma treatment. Thrombotic microangiopathy is accompanied by a decrease in red blood cells and cells involved in clotting (platelets) and can be fatal. These blood clots could affect your child&rsquo;s kidneys. Your child&rsquo;s doctor may want to check your child&rsquo;s blood (platelet counts) and blood pressure. Possible signs you need to look out for after your child is given Zolgensma include bruising easily, seizures (fits) or decrease in urine output (see section&nbsp;4 for more information). Seek urgent medical attention if your child develops any of these signs.</p><p>&nbsp;</p><p><u>Blood, organ, tissue and cell donation</u></p><p>After your child has been treated with Zolgensma, they will not be able to donate blood, organs, tissues or cells. This is because Zolgensma is a gene therapy medicine.</p><p>&nbsp;</p><p><strong>c.Taking other medicines and herbal or dietary supplements</strong></p><p>&nbsp;</p><p>Tell your child&rsquo;s doctor or nurse if your child is taking, has recently taken or might take any other medicines.</p><p>&nbsp;</p><p><u>Prednisolone</u></p><p>Your child will also be given a corticosteroid medicine such as prednisolone for about 2&nbsp;months or longer (see also section&nbsp;3) as part of Zolgensma treatment. The corticosteroid medicine will help manage any increase in liver enzymes that your child could develop after being given Zolgensma.</p><p>&nbsp;</p><p><u>Vaccinations</u></p><p>As corticosteroids can affect the body&rsquo;s immune (defense) system,<strong> your child&rsquo;s doctor may decide to delay giving some vaccinations </strong>while your child is receiving corticosteroid treatment. Talk to your child&rsquo;s doctor or nurse if you have any questions.</p><p>&nbsp;</p><p><strong>Zolgensma contains sodium</strong></p><p>This medicine contains 4.6&nbsp;mg sodium per&nbsp;mL, equivalent to 0.23% of the WHO recommended maximum daily intake of 2&nbsp;g&nbsp;sodium for an adult. Each 5.5‑mL&nbsp;vial contains 25.3&nbsp;mg sodium, and each 8.3‑mL vial contains 38.2&nbsp;mg sodium.</p><p>&nbsp;</p><p><strong>Additional information for parents/caregiver</strong></p><p>&nbsp;</p><p><u>Advanced SMA</u></p><p>Zolgensma can rescue living motor neurons, but does not rescue dead motor neurons. Children with less severe symptoms of SMA (such as absent reflexes or reduced muscle tone) may have sufficient living motor neurons to benefit significantly from Zolgensma treatment. Zolgensma may not work as well in children with severe muscle weakness or paralysis, breathing problems or who are not able to swallow, or in children who have significant malformations (such as heart defects), including patients with SMA Type&nbsp;0, as there may be limited potential improvement after treatment with Zolgensma. Your child&rsquo;s doctor will decide if your child should be given this medicine.</p><p>&nbsp;</p><p>Risk of tumours associated with potential insertion into the DNA</p><p>There is a possibility that therapies such as Zolgensma can insert into the DNA of human body cells. As a consequence, Zolgensma could contribute to a risk of tumours because of the nature of the medicine. You should discuss this with your child&rsquo;s doctor. In the event of a tumour, your child&rsquo;s doctor may take a sample for further evaluation.</p><p>&nbsp;</p><p><u>Hygiene care</u></p><p>The active substance in Zolgensma may temporarily be excreted through your child&rsquo;s bodily waste; this is called &lsquo;shedding&rsquo;. Parents and caregivers should follow good hand-hygiene for up to 1&nbsp;month after your child is given Zolgensma. Wear protective gloves when coming into direct contact with your child&rsquo;s bodily fluids or waste and wash hands thoroughly afterwards with soap and warm running water, or an alcohol-based hand sanitiser. Double bags should be used to dispose of soiled nappies and other waste. Disposable nappies may still be disposed of in household waste.</p><p>&nbsp;</p><p>You should continue to follow these instructions for at least 1&nbsp;month after your child&rsquo;s treatment with Zolgensma. Talk to your child&rsquo;s doctor or nurse if you have any questions.</p><p><strong>a.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>Do NOT use Zolgensma</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if your child is allergic to onasemnogene abeparvovec or any of the other ingredients of this medicine (listed in section&nbsp;6).</p><p>&nbsp;</p><p><strong>b.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>Take special care with Zolgensma</strong></p><p>Your child&rsquo;s doctor will check for antibodies before treatment to help decide if this medicine is suitable for your child.</p><p><u>&nbsp;</u></p><p><u>Liver problems</u></p><p>Talk to your child&rsquo;s doctor or nurse before this medicine is given if your child has had any liver problems. This medicine can lead to an increase in enzymes (proteins found within the body) produced by the liver or injury to the liver. Injury to the liver can lead to serious outcomes, including liver failure and death. Possible signs you need to look out for after your child is given this medicine include vomiting, jaundice (yellowing of the skin or of the whites of the eyes), or reduced alertness (see section&nbsp;4 for more information). Tell your child&rsquo;s doctor straightaway if you notice your child develops any symptoms suggestive of injury to the liver.</p><p>Your child will have a blood test to check how well the liver is working before starting treatment with Zolgensma. Your child will also have regular blood tests for at least 3&nbsp;months after treatment to monitor for increases in liver enzymes.</p><p><u>Infection</u></p><p>An infection (e.g. cold, flu or bronchiolitis) before or after Zolgensma treatment may lead to more serious complications. Caregivers and close contacts with the patient should follow infection prevention practices (e.g. hand hygiene, coughing/sneezing etiquette, limiting potential contacts). You need to look out for signs of an infection such as coughing, wheezing, sneezing, runny nose, sore throat or fever. Tell your child&rsquo;s doctor straightaway if you notice your child develops any symptoms suggestive of infection <strong>before</strong> or <strong>after</strong> Zolgensma treatment.</p><p><u>Regular blood tests</u></p><p>This medicine can lower blood-platelet counts (thrombocytopenia). You need to look out for possible signs of a low blood-platelet count after your child is given Zolgensma such as abnormal bruising or bleeding (see section&nbsp;4 for more information).</p><p>Zolgensma can raise levels of a heart protein called troponin-I that may indicate injury to the heart. You need to look out for possible signs of heart problems after your child is given this medicine, such as pale grey or blue skin colour, difficulty in breathing, swelling of the arms and legs or of the belly (see section&nbsp;4 for more information).</p><p>Before starting treatment with Zolgensma, your child will have a blood test to check the amount of blood cells (including red blood cells and platelets), as well as troponin-I level in their body. They will also have a blood test to check their creatinine level, which is an indicator of how the kidneys are working. Your child will also have regular blood tests for a period of time after treatment to monitor for changes in platelets and troponin-I levels.</p><p>&nbsp;</p><p><u>Abnormal clotting of blood in small blood vessels (thrombotic microangiopathy)</u></p><p>There have been reports of patients developing thrombotic microangiopathy generally within the first two weeks after Zolgensma treatment. Thrombotic microangiopathy is accompanied by a decrease in red blood cells and cells involved in clotting (platelets) and can be fatal. These blood clots could affect your child&rsquo;s kidneys. Your child&rsquo;s doctor may want to check your child&rsquo;s blood (platelet counts) and blood pressure. Possible signs you need to look out for after your child is given Zolgensma include bruising easily, seizures (fits) or decrease in urine output (see section&nbsp;4 for more information). Seek urgent medical attention if your child develops any of these signs.</p><p>&nbsp;</p><p><u>Blood, organ, tissue and cell donation</u></p><p>After your child has been treated with Zolgensma, they will not be able to donate blood, organs, tissues or cells. This is because Zolgensma is a gene therapy medicine.</p><p>&nbsp;</p><p><strong>c.Taking other medicines and herbal or dietary supplements</strong></p><p>Tell your child&rsquo;s doctor or nurse if your child is taking, has recently taken or might take any other medicines.</p><p>&nbsp;</p><p><u>Prednisolone</u></p><p>Your child will also be given a corticosteroid medicine such as prednisolone for about 2&nbsp;months or longer (see also section&nbsp;3) as part of Zolgensma treatment. The corticosteroid medicine will help manage any increase in liver enzymes that your child could develop after being given Zolgensma.</p><p>&nbsp;</p><p><u>Vaccinations</u></p><p>As corticosteroids can affect the body&rsquo;s immune (defense) system,<strong> your child&rsquo;s doctor may decide to delay giving some vaccinations </strong>while your child is receiving corticosteroid treatment. Talk to your child&rsquo;s doctor or nurse if you have any questions.</p><p>&nbsp;</p><p><strong>Zolgensma contains sodium</strong></p><p>This medicine contains 4.6&nbsp;mg sodium per&nbsp;mL, equivalent to 0.23% of the WHO recommended maximum daily intake of 2&nbsp;g&nbsp;sodium for an adult. Each 5.5‑mL&nbsp;vial contains 25.3&nbsp;mg sodium, and each 8.3‑mL vial contains 38.2&nbsp;mg sodium.</p><p>&nbsp;</p><p><strong>Additional information for parents/caregiver</strong></p><p><u>Advanced SMA</u></p><p>Zolgensma can rescue living motor neurons, but does not rescue dead motor neurons. Children with less severe symptoms of SMA (such as absent reflexes or reduced muscle tone) may have sufficient living motor neurons to benefit significantly from Zolgensma treatment. Zolgensma may not work as well in children with severe muscle weakness or paralysis, breathing problems or who are not able to swallow, or in children who have significant malformations (such as heart defects), including patients with SMA Type&nbsp;0, as there may be limited potential improvement after treatment with Zolgensma. Your child&rsquo;s doctor will decide if your child should be given this medicine.</p><p>&nbsp;</p><p><u>Hygiene care</u></p><p>The active substance in Zolgensma may temporarily be excreted through your child&rsquo;s bodily waste; this is called &lsquo;shedding&rsquo;. Parents and caregivers should follow good hand-hygiene for up to 1&nbsp;month after your child is given Zolgensma. Wear protective gloves when coming into direct contact with your child&rsquo;s bodily fluids or waste and wash hands thoroughly afterwards with soap and warm running water, or an alcohol-based hand sanitiser. Double bags should be used to dispose of soiled nappies and other waste. Disposable nappies may still be disposed of in household waste.</p><p>&nbsp;</p><p>You should continue to follow these instructions for at least 1&nbsp;month after your child&rsquo;s treatment with Zolgensma. Talk to your child&rsquo;s doctor or nurse if you have any questions.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>How Zolgensma is given</strong></p><p>&nbsp;</p><p>Zolgensma will be given by a doctor or nurse trained in the management of your child&rsquo;s condition.</p><p>&nbsp;</p><p>The doctor will work out the amount of Zolgensma your child will receive according to your child&rsquo;s weight. Zolgensma is given intravenously (into a vein) by a single infusion (drip) over about 1&nbsp;hour.</p><p>&nbsp;</p><p><strong>Zolgensma will be given to your child ONCE only.</strong></p><p>&nbsp;</p><p>Your child will also be given prednisolone (or another corticosteroid) by mouth, starting 24&nbsp;hours before being given Zolgensma. The dose of corticosteroid will also depend on your child&rsquo;s weight. Your child&rsquo;s doctor will work out the total dose to give.</p><p>&nbsp;</p><p>Your child will be given corticosteroid treatment daily for about 2&nbsp;months after the dose of Zolgensma, or until your child&rsquo;s liver enzymes decrease to an acceptable level. The doctor will slowly reduce the dose of corticosteroid until treatment can be fully stopped.</p><p>&nbsp;</p><p>If you have any further questions ask your child&rsquo;s doctor or nurse.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can have side effects, although not everybody gets them.</p><p>&nbsp;</p><p><strong>Seek urgent medical attention</strong> if your child develops any of the following serious side effects:</p><p>&nbsp;</p><p><strong>Common</strong> (may affect up to 1&nbsp;in&nbsp;10&nbsp;people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; bruising or bleeding for longer than usual if your child has been hurt &ndash; these may be signs of a low blood-platelet count;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pale grey or blue skin colour, difficulty in breathing (e.g. rapid breathing, shortness of breath), swelling of the arms and legs or of the belly &ndash; these may be signs of possible problems with the heart.</p><p>&nbsp;</p><p><strong>Uncommon </strong>(may affect up to 1 in 100&nbsp;people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; vomiting, jaundice (yellowing of the skin or of the whites of the eyes) or reduced alertness - these may be signs of injury to the liver (including liver failure).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; bruising easily, seizures (fits), decrease in urine output &ndash; these may be signs of thrombotic microangiopathy.</p><p>&nbsp;</p><p>Talk to your child&rsquo;s doctor or nurse if your child develops any other side effects. These can include:</p><p>&nbsp;</p><p><strong>Very common </strong>(may affect more than 1 in 10&nbsp;people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increases in liver enzymes seen in blood tests.</p><p>&nbsp;</p><p><strong>Common</strong> (may affect up to 1&nbsp;in&nbsp;10&nbsp;people):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; vomiting;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fever.</p><p>&nbsp;</p><p><strong>Reporting of side effects</strong></p><p>If your child gets any side effects, talk to your child&rsquo;s doctor or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly. By reporting side effects, you can help provide more information on the safety of this medicine.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep this medicine out of the sight and reach of children.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The following information is for healthcare professionals who will prepare and give the medicine.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use this medicine after the expiry date which is stated on the vial label and carton after EXP. The expiry date refers to the last day of that month.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vials will be transported frozen (at or below ‑60&ordm;C).</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Upon receipt vials should be refrigerated at 2&deg;C&nbsp;to&nbsp;8&deg;C immediately, and in the original carton. Zolgensma therapy should be initiated within 14&nbsp;days of receipt of vials.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; This medicine contains genetically-modified organisms. Unused medicine or waste material must be disposed of in compliance with the local guidelines on handling of biological waste. As this medicine will be given by a doctor, the doctor is responsible for the correct disposal of the product. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>a.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>What </strong><strong>Zolgensma contains</strong></p><p><strong>&nbsp;</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The active substance is onasemnogene abeparvovec. Each vial contains onasemnogene abeparvovec with a nominal concentration of 2&nbsp;&times;&nbsp;10<sup>13</sup>&nbsp;vector genomes/mL.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The other ingredients are tromethamine, magnesium chloride, sodium chloride, poloxamer 188, hydrochloric acid (for pH adjustment) and water for injections.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Zolgensma is a clear to slightly opaque, colourless to faint white solution for infusion.

Zolgensma may be supplied in vials containing a nominal fill volume of either of 5.5 mL or 8.3 mL. Each vial is for single use only.

Each carton will contain between 2 to 14 vials.

Not all pack sizes may be marketed in your country.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The Marketing Authorization Holder for this Product is Novartis Europharm Limited.</p><p>www.Novartis.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last approved in 03/2024 by EMA.

e. To report any side effect(s):

•	Saudi Arabia
The National Pharmacovigilance Center (NPC):
o SFDA call center: 19999
o E-mail: npc.drug@sfda.gov.sa
o Website: https://ade.sfda.gov.sa 

Patient Safety Department Novartis Consulting AG - Saudi Arabia:
o Toll Free Number: 8001240078
o Phone: +966112658100 
o Fax: +966112658107
o Email: adverse.events@novartis.com  

•    Other GCC States:
-  Please contact the relevant competent authority.

To report any complaint(s): complaints.ksa@novartis.com

            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL"><strong>ما هو دواء زولجنزما</strong></p><p dir="RTL">زولجنزما هو نوع من الأدوية يُسمَّى &quot;العلاج الجيني&quot;. يحتوي على المادة الفعالة أوناسمنوجين أبيبارفوفك، التي تحتوي على مادة وراثية بشرية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>دواعي استعمال زولجنزما</strong></p><p dir="RTL">يُستخدم زولجنزما لعلاج ضمور العضلات الشوكي (SMA)، وهو مرض وراثي نادر وخطير.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>كيفية عمل دواء زولجنزما</strong></p><p dir="RTL">يحدث ضمور العضلات الشوكي عندما يكون هناك نسخة مفقودة أو معيبة من جين لازم لصنع بروتين أساسي يُسمى بروتين &quot;العصبون الحركي المتعلق بالبقاء على قيد الحياة&quot; (SMN). يؤدي نقص بروتين SMN إلى موت الأعصاب التي تتحكم في العضلات (العصبونات الحركية). ويؤدي ذلك إلى ضعف العضلات وضمورها، مع فقدان الحركة في نهاية المطاف.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يعمل هذا الدواء من خلال توفير نسخة كاملة الوظائف من جين SMN مما يساعد الجسم بعد ذلك على إنتاج كميات كافية من بروتين SMN. ويتم توصيل الجين إلى الخلايا حيث تكون هناك حاجة إليه باستخدام فيروس معدل لا يسبب مرضًا لدى البشر.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>&zwnj;أ.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>موانع استعمال دواء زولجنزما</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لدى طفلك حساسية تجاه أوناسمنوجين أبيبارفوفك أو أي من مكونات هذا الدواء (المذكورة في القسم 6).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&zwnj;ب.&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>الاحتياطات عند استعمال دواء زولجنزما</strong></p><p dir="RTL">سيُفحص طفلك من قِبل طبيبه بحثًا عن أجسام مضادة قبل العلاج للمساعدة في تحديد ما إذا كان هذا الدواء مناسبًا له أم لا.</p><p dir="RTL"><u>&nbsp;</u></p><p dir="RTL"><u>مشكلات الكبد</u></p><p dir="RTL">تحدث إلى طبيب طفلك أو الممرضة قبل إعطاء هذا الدواء إذا كان طفلك يعاني من أي مشكلات في الكبد. فقد يؤدي هذا الدواء إلى زيادة في الإنزيمات (بروتينات موجودة داخل الجسم) التي ينتجها الكبد أو إصابة الكبد.&nbsp; يمكن أن تؤدي إصابة الكبد إلى نتائج خطيرة ، بما في ذلك الفشل الكبدي والوفاة. من بين العلامات المحتملة التي تحتاج إلى الانتباه لها بعد إعطاء طفلك هذا الدواء التقيؤ، أو اليرقان (اصفرار الجلد أو بياض العينين)، أو قلة اليقظة (انظر القسم 4 لمزيد من المعلومات). أخبر طبيب طفلك على الفور إذا لاحظت ظهور أي أعراض على طفلك توحي بإصابة الكبد.</p><p dir="RTL">&nbsp;</p><p dir="RTL">سيخضع طفلك لاختبار دم للتحقق من مدى كفاءة عمل وظائف الكبد قبل بدء العلاج بدواء زولجنزما. سيخضع طفلك أيضًا لفحوصات دم منتظمة لمدة 3 أشهر على الأقل بعد العلاج لرصد أي زيادات في إنزيمات الكبد.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>العدوى</u></p><p dir="RTL">قد تؤدي الإصابة بعدوى (مثل البرد أو الإنفلونزا أو التهاب القصيبات) قبل إعطاء علاج زولجنزما أو بعد إعطائه إلى حدوث مضاعفات أكثر خطورة. يجب على مقدمي الرعاية والمخالطين القريبين للمريض اتباع ممارسات الوقاية من العدوى (مثل نظافة اليدين ، وآداب السعال / العطس ، والحد من الاتصالات المحتملة). كذلك يتعين عليك الانتباه إلى علامات العدوى مثل السعال، أو الأزيز، أو العطاس، أو سيلان الأنف، أو التهاب الحلق، أو الحمى. أخبر طبيب طفلك على الفور إذا لاحظت أن طفلك يعاني م هذه الأعراض التي توحي بالعدوى قبل او بعد العلاج بزولجنزما.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>اختبارات الدم المنتظمة</u></p><p dir="RTL">يمكن لهذا الدواء أن يقلل من تعداد الصفائح الدموية (قلة الصفيحات). ويتعين عليك الانتباه إلى العلامات المحتملة لانخفاض عدد الصفائح الدموية بعد إعطاء طفلك زولجنزما مثل أي تكدم أو نزف غير طبيعي (انظر القسم 4 لمزيد من المعلومات).حدثت معظم الحالات المبلغ عنها لانخفاض عدد الصفائح الدموية خلال الأسابيع الثلاثة الأولى بعد إعطاء الطفل زولجنزما.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يمكن أن يُزيد دواء زولجنزما من مستويات أحد بروتينات القلب يُسمى تروبونين I و&rlm;الذي قد يُشير إلى وجود إصابة بالقلب. يجب عليك الانتباه للعلامات المحتملة لمشكلات القلب بعد إعطاء طفلك هذا الدواء، مثل لون الجلد الرمادي الشاحب أو الأزرق، أو صعوبة التنفس، أو تورم الذراعين والساقين أو البطن (انظر القسم 4 لمزيد من المعلومات).</p><p dir="RTL">&nbsp;</p><p dir="RTL">قبل بدء العلاج بدواء زولجنزما، سيخضع طفلك لاختبار دم لفحص كمية خلايا الدم (بما في ذلك خلايا الدم الحمراء والصفائح الدموية)،&nbsp;وكذلك مستوى تروبونين-I في جسمه. كما سيخضع أيضًا لاختبار دم لفحص مستوى الكرياتينين لديه، وهو مؤشر على كيفية عمل الكلى. سيخضع طفلك أيضًا لاختبارات دم منتظمة لفترة من الوقت بعد العلاج لرصد أي تغيرات قد تحدث في الصفائح الدموية ومستويات&nbsp;التروبونين-I.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>تخثر غير طبيعي للدم في الأوعية الدموية الصغيرة (اعتلال الأوعية الدقيقة الخثاري)</u></p><p dir="RTL">وردت تقارير عن إصابة مرضى باعتلال الأوعية الدقيقة الخثاري بشكل عام خلال الاسوعين الاولين بعد من تلقي العلاج بدواء زولجنزما. يُصاحب اعتلال الأوعية الدقيقة الخثاري انخفاض في خلايا الدم الحمراء والخلايا التي تلعب دورًا في التخثر (الصفائح الدموية) و يمكن ان تؤدي الى الوفاة. قد تؤثر هذه الجلطات الدموية على كليتي طفلك. وقد يرغب الطبيب في فحص دم طفلك (عدد الصفائح الدموية) وقياس ضغط دمه. تشمل العلامات المحتملة التي يجب عليك الانتباه لها بعد إعطاء طفلك دواء زولجنزما سهولة التكدم، أو تشنجات، أو انخفاض في وتيرة إخراج البول (انظر القسم 4 لمزيد من المعلومات). اطلب الرعاية الطبية العاجلة إذا ظهرت على طفلك أي من هذه العلامات.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>التبرع بالدم والأعضاء والأنسجة والخلايا</u></p><p dir="RTL">بعد معالجة طفلك بدواء زولجنزما، لن يتمكن طفلك من التبرع بالدم أو الأعضاء أو الأنسجة أو الخلايا. وذلك لأن زولجنزما هو علاج&nbsp;جيني.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&zwnj;ج.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>التداخلات الدوائية من أخذ دواء زولجنزما مع أدوية أخرى أو أعشاب او مكملات غذائية</strong></p><p dir="RTL">أخبر طبيب طفلك أو ممرضته بما إذا كان طفلك يتناول، أو تناول مؤخرًا، أو قد يتناول أي أدوية أخرى.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>بريدنيزولون</u></p><p dir="RTL">سيُعطى طفلك أيضًا دواء كورتيكوستيرويد مثل بريدنيزولون لمدة شهرين أو أكثر (انظر أيضًا القسم 3) كجزء من علاج زولجنزما. سيساعد دواء الكورتيكوستيرويد في السيطرة على أي زيادة في إنزيمات الكبد يمكن أن يصاب بها طفلك بعد إعطائه دواء زولجنزما.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>اللقاحات</u></p><p dir="RTL">نظرًا لأن الكورتيكوستيرويدات يمكن أن تؤثر على جهاز المناعة (الدفاع) في الجسم،<strong> فقد يقرر طبيب طفلك تأخير إعطاء بعض اللقاحات </strong>أثناء تلقي طفلك العلاج بالكورتيكوستيرويدات. تحدث إلى طبيب طفلك أو ممرضته إذا كانت لديك أي أسئلة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>يحتوي زولجنزما على الصوديوم</strong></p><p dir="RTL">يحتوي هذا الدواء على 4.6 مجم من الصوديوم لكل مل، ما يعادل 0.23% من الحد الأقصى الموصى به من الجرعة اليومية المقدرة بـ 2 جم صوديوم للبالغين وفق المنظمة الصحة العالمية. تحتوي كل قارورة سعة 5.5 مل على 25.3 مجم من الصوديوم، وتحتوي كل قارورة سعة 8.3 مل على 38.2 مجم من الصوديوم.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>معلومات إضافية للوالدين/مقدم الرعاية</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>ضمور العضلات الشوكي المتقدم</u></p><p dir="RTL">يمكن أن ينقذ دواء زولجنزما الخلايا العصبية الحركية الحية، ولكنه لا ينقذ الخلايا العصبية الحركية الميتة. قد يكون لدى الأطفال الذين يعانون من أعراض أقل شدة لضمور العضلات الشوكي (مثل ردود الفعل الغائبة أو انخفاض قوة العضلات) كميات كافية من الخلايا العصبية الحركية الحية للاستفادة بشكل كبير من علاج زولجنزما. قد لا يكون دواء زولجنزما فعالاً بشكل جيد لدى الأطفال الذين يعانون من ضعف شديد في العضلات أو شلل، أو مشكلات في التنفس أو الذين لا يستطيعون البلع، أو لدى الأطفال الذين يعانون من عيوب كبيرة (مثل عيوب القلب)، بما في ذلك المرضى المصابين بضمور العضلات الشوكي من النوع0 (صفر) ، حيث قد يكون هناك تحسّن محدود محتمل بعد تلقي العلاج بدواء زولجنزما. وسيُقرر طبيب طفلك ما إذا كان ينبغي إعطاء طفلك هذا الدواء أم لا.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>خطر الأورام المرتبطة بإمكانيه اختراقها للحمض النووي</u></p><p dir="RTL">توجد احتماليه بان بعض العلاجات مثل زولجنزما تستطيع اختراق الحمض النووي في خليه الانسان. ونتيجه لذلك, زولجنزما قد يساهم في خطر الإصابه بالأورام نظرا لطبيعة هذا الدواء. يجب عليك مناقشة هذا الأمر مع طبيب طفلك. في حالة وجود ورم, قد يأخذ طبيب طفلك عينات للمزيد من التقييم.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>النظافة الشخصية</u></p><p dir="RTL">قد تُفرز المادة الفعالة الموجودة في زولجنزما مؤقتًا من خلال فضلات طفلك؛ وهذا ما يُسمى &quot;التناثر&quot;. يجب على الآباء ومقدمي الرعاية اتباع ممارسات نظافة اليدين الجيدة لمدة تصل إلى شهر واحد بعد إعطاء طفلك دواء زولجنزما. ارتدِ قفازات واقية عند ملامسة سوائل الجسم أو البراز الخاص بطفلك بشكل مباشر واغسل يديك جيدًا بعد ذلك بالماء الجاري الدافئ والصابون أو بمطهر لليدين يحتوي على الكحول. كما يجب استخدام أكياس مزدوجة للتخلص من الحفاضات المتسخة والنفايات الأخرى. يمكن التخلص من الحفاضات التي تُستخدم لمرة واحدة في النفايات المنزلية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب أن تستمر في اتباع هذه التعليمات لمدة شهر واحد على الأقل بعد تلقي طفلك العلاج بدواء زولجنزما. تحدث إلى طبيب طفلك أو ممرضته إذا كانت لديك أي أسئلة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>كيفية إعطاء زولجنزما</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">سيتم إعطاء زولجنزما من قِبل طبيب أو ممرضة مدربة على إدارة حالة طفلك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">سيحدد الطبيب كمية زولجنزما التي سيتلقاها طفلك حسب وزنه. يتم إعطاء زولجنزما عن طريق تسريب واحد (تنقيط) في الوريد على مدار ساعة واحدة تقريبًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>سيتم إعطاء زولجنزما لطفلك مرة واحدة فقط.</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">كما سيتم إعطاء طفلك بريدنيزولون (أو كورتيكوستيرويد آخر) عن طريق الفم، قبل 24 ساعة من إعطائه زولجنزما. هذا وستعتمد جرعة الكورتيكوستيرويد أيضًا على وزن طفلك. وسيحدد طبيب طفلك الجرعة الإجمالية التي يجب إعطاؤها.</p><p dir="RTL">&nbsp;</p><p dir="RTL">سيُعطى طفلك علاج بالكورتيكوستيرويدات يوميًا لمدة شهرين تقريبًا بعد إعطاء جرعة زولجنزما، أو حتى تنخفض إنزيمات الكبد لديه إلى مستوى مقبول. وسيُقلل الطبيب جرعة الكورتيكوستيرويد تدريجيًا حتى يمكن إيقاف العلاج تمامًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">- إذا كانت لديك أي أسئلة إضافية، فاطرحها على طبيب طفلك أو الممرضة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، قد يسبب هذا الدواء آثارًا جانبية، على الرغم من عدم حدوثها لدى الجميع.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>اطلب الرعاية الطبية العاجلة</strong> إذا ظهرت على طفلك أي من الآثار الجانبية الخطيرة التالية:</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>شائعة</strong> (قد تصيب ما يصل إلى شخص واحد من بين كل 10 أشخاص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تكدم أو نزف لفترة أطول من المعتاد إذا أصيب طفلك - قد تكون هذه علامات على انخفاض عدد الصفائح الدموية؛</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لون الجلد الرمادي الشاحب أو الأزرق، صعوبة في التنفس (مثل سرعة التنفس، ضيق التنفس)، تورّم الذراعين والساقين أو البطن - قد تكون هذه الأعراض علامات على وجود مشكلات محتملة في القلب.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>شائعة</strong> (قد تصيب ما يصل إلى شخص واحد من بين كل 100 شخص</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التقيؤ، أو اليرقان (اصفرار الجلد أو بياض العينين) أو قلة اليقظة - قد تكون هذه الأعراض علامات على إصابة الكبد.(بما في ذلك فشل الكبد)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سهولة التكدّم، تشنجات، انخفاض وتيرة إخراج البول - قد تكون هذه الأعراض علامات على اعتلال الأوعية الدقيقة الخثاري.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تحدث إلى طبيب طفلك أو الممرضة إذا ظهرت على طفلك أي آثار جانبية أخرى. ويمكن أن تشمل ما يلي:</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>شائعة جدًا </strong>(قد تصيب أكثر من شخص واحد من كل 10 أشخاص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في إنزيمات الكبد والتي لوحظت في اختبارات الدم.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>شائعة </strong>(قد تصيب ما يصل إلى شخص واحد من كل 10 أشخاص):</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التقيؤ؛</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحمى.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الإبلاغ عن الآثار الجانبية</strong></p><p dir="RTL">إذا عانى طفلك من أي آثار جانبية، فتحدّث إلى طبيب طفلك أو الممرضة. وهذا يشمل أيّة آثار جانبية محتملة غير مدرجة في هذه النشرة. يمكنك أيضًا الإبلاغ عن الآثار الجانبية مباشرةً. بإبلاغك عن الآثار الجانبية، فإنّك تساعد في توفير المزيد من المعلومات حول سلامة هذا&nbsp;الدواء.</p><p dir="RTL">مثل جميع الأدوية، قد يسبب هذا الدواء آثارًا جانبية، على الرغم من عدم حدوثها لدى الجميع.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احفظ هذا الدواء بعيدًا عن مرأى الأطفال ومتناولهم.</p><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المعلومات التالية مخصصة لاختصاصيي الرعاية الصحية الذين سيقومون بتحضير الدواء وإعطائه.</p><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المدوَّن على ملصق القارورة والعلبة الكرتونية بعد كلمة &quot;EXP&quot;. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سيتم نقل القوارير مجمدة (عند درجة حرارة -60 درجة مئوية أو أقل).</p><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عند الاستلام، يجب تبريد القوارير في درجة حرارة تتراوح بين 2 و8 درجات مئوية على الفور، وفي العلبة الكرتونية الأصلية. يجب بدء العلاج بدواء زولجنزما في غضون 14 يومًا من استلام القوارير.</p><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحتوي هذا المنتج على كائنات حية مُعدَّلة وراثيًا. يجب التخلص من الأدوية غير المستخدمة أو النفايات وفقًا للإرشادات المحلية الخاصة بالتعامل مع النفايات البيولوجية. نظرًا لأن الطبيب سيُعطي هذا الدواء، فإن الطبيب مسؤول عن التخلص الصحيح من المنتج. ستساعد هذه الإجراءات على حماية البيئة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المادة الفعالة هي أوناسمنوجين أبيبارفوفك. تحتوي كل قارورة على أوناسمنوجين أبيبارفوفك بتركيز اسمي يبلغ 2 &times; 10<sup>13</sup> جينوم ناقل/مل.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المكونات الأخرى هي تروميثامين، وكلوريد المغنيسيوم، وكلوريد الصوديوم، وبولوكسامير 188، وحمض الهيدروكلوريك (لتعديل درجة الحموضة) وماء للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">زولجنزما هو محلول شفاف إلى معتم قليلاً، عديم اللون إلى أبيض باهت مُعد للتسريب.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يتم توفير زولجنزما في قوارير تحتوي على حجم تعبئة اسمي يبلغ إما 5.5 مل أو 8.3 مل. كل قارورة مخصصة للاستخدام مرة واحدة فقط.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ستحتوي كل كرتونة على ما بين 2 إلى 14 قارورة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد لا يتم تسويق جميع أحجام العبوات في بلدك</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مالك حق التسويق لهذا المنتج هي شركة نوفارتس یوروفارم المحدودة، إیرلندا</p><p dir="RTL">www.Novartis.com</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تم آخر إعتماد لهذه النشرة من قِبل منظمة الأدوية الأوروبية في تاريخ 03/2024.

‌ه.	 للإبلاغ عن الاعراض الجانبية:

•	المملكة العربية السعودية
المركز الوطني للتيقظ والسلامة الدوائية (NPC):
o	مركز اتصال الهيئة السعودية للغذاء والدواء: 19999
o	البريد الإلكتروني: npc.drug@sfda.gov.sa
o	الموقع الإلكتروني: https://ade.sfda.gov.sa/‎

قسم سلامة المرضى بشركة نوفارتيس كونسالتينج أيه جي - المملكة العربية السعودية:
o	الرقم المجاني: 8001240078
o	الهاتف: 966112658100+
o	الفاكس: 966112658107+
o	البريد الإلكتروني: adverse.events@novartis.com 

• دول مجلس التعاون الخليجي الأخرى:
- يُرجى الاتصال بالسلطة المختصة ذات الصلة.
للإبلاغ عن أي شكاوى: complaints.ksa@novartis.com

        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Zolgensma 2 × 1013 vector genomes/mL suspension for intravenous infusion
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2.1	General description

Onasemnogene abeparvovec is a gene therapy medicinal product that expresses the human survival motor neuron (SMN) protein. It is a non-replicating recombinant adeno-associated virus serotype 9 (AAV9) based vector containing the cDNA of the human SMN gene under the control of the cytomegalovirus enhancer/chicken-β-actin-hybrid promoter.

Onasemnogene abeparvovec is produced in human embryonic kidney cells by recombinant DNA technology.

2.2	Qualitative and quantitative composition

Each mL contains onasemnogene abeparvovec with a nominal concentration of 2 × 1013 vector genomes (vg). Vials will contain an extractable volume of not less than either 5.5 mL or 8.3 mL. The total number of vials and combination of fill volumes in each finished pack will be customised to meet dosing requirements for individual patients depending on their weight (see sections 4.2 and 6.5).

Excipient with known effect
This medicinal product contains 0.2 mmol sodium per mL.

For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Suspension for intravenous infusion.
A clear to slightly opaque, colourless to faint white solution.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Zolgensma is indicated for the treatment of:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; patients with 5q spinal muscular atrophy (SMA) with a bi-allelic mutation in the <em>SMN1</em> gene and a clinical diagnosis of SMA Type&nbsp;1, or</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; patients with 5q SMA with a bi-allelic mutation in the <em>SMN1</em> gene and up to 3&nbsp;copies of the <em>SMN2</em> gene.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment should be initiated and administered in clinical centres and supervised by a physician experienced in the management of patients with SMA.</p><p>&nbsp;</p><p>Before administration of onasemnogene abeparvovec, baseline laboratory testing is required, including, but not limited to:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; AAV9&nbsp;antibody testing using an appropriately validated assay,liver function: alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin, albumin, prothrombin time, partial thromboplastin time (PTT), and international normalised ratio (INR),</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; creatinine,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; complete blood count (including haemoglobin and platelet count), and</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; troponin-I.</p><p>&nbsp;</p><p>The need for close monitoring of liver function, platelet count and troponin-I after administration and the need for corticosteroid treatment are to be considered when establishing the timing of onasemnogene abeparvovec treatment (see section&nbsp;4.4).</p><p>&nbsp;</p><p>Due to the increased risk of serious systemic immune response, it is recommended that patients are clinically stable in their overall health status (e.g. hydration and nutritional status, absence of infection) prior to onasemnogene abeparvovec infusion.In case of acute or chronic uncontrolled active infections, treatment should be postponed until the infection has resolved and the patient is clinically stable (see sub-sections&nbsp;4.2 &lsquo;Immunomodulatory regimen&rsquo;and 4.4 &lsquo;Systemic immune response&rsquo;).</p><p>&nbsp;</p><p><u>Posology</u></p><p>&nbsp;</p><p>For single-dose intravenous infusion only.</p><p>&nbsp;</p><p>Patients will receive a dose of nominal 1.1&nbsp;x&nbsp;10<sup>14</sup>&nbsp;vg/kg onasemnogene abeparvovec. The total volume is determined by patient body weight.</p><p>&nbsp;</p><p>Table&nbsp;1 gives the recommended dosing for patients who weigh 2.6&nbsp;kg to 21.0&nbsp;kg.</p><p>&nbsp;</p><p><strong>Table&nbsp;1 Recommended dosing based on patient body weight</strong></p><table border="0" cellspacing="0" cellpadding="0" style="width:576px"><thead><tr><td><p><strong>Patient weight range (kg)</strong></p></td><td><p><strong>Dose (vg)</strong></p></td><td><p><strong>Total volume of dose <sup>a</sup> (mL)</strong></p></td></tr></thead><tbody><tr><td><p>2.6 &ndash; 3.0</p></td><td><p>3.3 &times; 10<sup>14</sup></p></td><td><p>16.5</p></td></tr><tr><td><p>3.1 &ndash; 3.5</p></td><td><p>3.9 &times; 10<sup>14</sup></p></td><td><p>19.3</p></td></tr><tr><td><p>3.6 &ndash; 4.0</p></td><td><p>4.4 &times; 10<sup>14</sup></p></td><td><p>22.0</p></td></tr><tr><td><p>4.1 &ndash; 4.5</p></td><td><p>5.0 &times; 10<sup>14</sup></p></td><td><p>24.8</p></td></tr><tr><td><p>4.6 &ndash; 5.0</p></td><td><p>5.5 &times; 10<sup>14</sup></p></td><td><p>27.5</p></td></tr><tr><td><p>5.1 &ndash; 5.5</p></td><td><p>6.1 &times; 10<sup>14</sup></p></td><td><p>30.3</p></td></tr><tr><td><p>5.6 &ndash; 6.0</p></td><td><p>6.6 &times; 10<sup>14</sup></p></td><td><p>33.0</p></td></tr><tr><td><p>6.1 &ndash; 6.5</p></td><td><p>7.2 &times; 10<sup>14</sup></p></td><td><p>35.8</p></td></tr><tr><td><p>6.6 &ndash; 7.0</p></td><td><p>7.7 &times; 10<sup>14</sup></p></td><td><p>38.5</p></td></tr><tr><td><p>7.1 &ndash; 7.5</p></td><td><p>8.3 &times; 10<sup>14</sup></p></td><td><p>41.3</p></td></tr><tr><td><p>7.6 &ndash; 8.0</p></td><td><p>8.8 &times; 10<sup>14</sup></p></td><td><p>44.0</p></td></tr><tr><td><p>8.1 &ndash; 8.5</p></td><td><p>9.4 &times; 10<sup>14</sup></p></td><td><p>46.8</p></td></tr><tr><td><p>8.6 &ndash; 9.0</p></td><td><p>9.9&nbsp;&times;&nbsp;10<sup>14</sup></p></td><td style="vertical-align:bottom"><p>49.5</p></td></tr><tr><td><p>9.1 &ndash; 9.5</p></td><td><p>1.05&nbsp;&times;&nbsp;10<sup>15</sup></p></td><td style="vertical-align:bottom"><p>52.3</p></td></tr><tr><td><p>9.6 &ndash; 10.0</p></td><td><p>1.10&nbsp;&times;&nbsp;10<sup>15</sup></p></td><td style="vertical-align:bottom"><p>55.0</p></td></tr><tr><td><p>10.1 &ndash; 10.5</p></td><td><p>1.16&nbsp;&times;&nbsp;10<sup>15</sup></p></td><td style="vertical-align:bottom"><p>57.8</p></td></tr><tr><td><p>10.6 &ndash; 11.0</p></td><td><p>1.21 &times;&nbsp;10<sup>15</sup></p></td><td style="vertical-align:bottom"><p>60.5</p></td></tr><tr><td><p>11.1 &ndash; 11.5</p></td><td><p>1.27&nbsp;&times;&nbsp;10<sup>15</sup></p></td><td style="vertical-align:bottom"><p>63.3</p></td></tr><tr><td><p>11.6 &ndash; 12.0</p></td><td><p>1.32&nbsp;&times;&nbsp;10<sup>15</sup></p></td><td style="vertical-align:bottom"><p>66.0</p></td></tr><tr><td><p>12.1 &ndash; 12.5</p></td><td><p>1.38&nbsp;&times;&nbsp;10<sup>15</sup></p></td><td style="vertical-align:bottom"><p>68.8</p></td></tr><tr><td><p>12.6 &ndash; 13.0</p></td><td><p>1.43&nbsp;&times;&nbsp;10<sup>15</sup></p></td><td style="vertical-align:bottom"><p>71.5</p></td></tr><tr><td><p>13.1 &ndash; 13.5</p></td><td><p>1.49&nbsp;&times;&nbsp;10<sup>15</sup></p></td><td style="vertical-align:bottom"><p>74.3</p></td></tr><tr><td style="vertical-align:top"><p>13.6 &ndash; 14.0</p></td><td><p>1.54 &times;&nbsp;10<sup>15</sup></p></td><td style="vertical-align:bottom"><p>77.0</p></td></tr><tr><td style="vertical-align:top"><p>14.1 &ndash; 14.5</p></td><td><p>1.60 &times;&nbsp;10<sup>15</sup></p></td><td style="vertical-align:bottom"><p>79.8</p></td></tr><tr><td style="vertical-align:top"><p>14.6 &ndash; 15.0</p></td><td><p>1.65 &times;&nbsp;10<sup>15</sup></p></td><td style="vertical-align:bottom"><p>82.5</p></td></tr><tr><td style="vertical-align:top"><p>15.1 &ndash; 15.5</p></td><td><p>1.71 &times;&nbsp;10<sup>15</sup></p></td><td style="vertical-align:bottom"><p>85.3</p></td></tr><tr><td style="vertical-align:top"><p>15.6 &ndash; 16.0</p></td><td><p>1.76 &times;&nbsp;10<sup>15</sup></p></td><td style="vertical-align:bottom"><p>88.0</p></td></tr><tr><td style="vertical-align:top"><p>16.1 &ndash; 16.5</p></td><td><p>1.82 &times;&nbsp;10<sup>15</sup></p></td><td style="vertical-align:bottom"><p>90.8</p></td></tr><tr><td style="vertical-align:top"><p>16.6 &ndash; 17.0</p></td><td><p>1.87 &times;&nbsp;10<sup>15</sup></p></td><td style="vertical-align:bottom"><p>93.5</p></td></tr><tr><td style="vertical-align:top"><p>17.1 &ndash; 17.5</p></td><td><p>1.93 &times;&nbsp;10<sup>15</sup></p></td><td style="vertical-align:bottom"><p>96.3</p></td></tr><tr><td style="vertical-align:top"><p>17.6 &ndash; 18.0</p></td><td><p>1.98 &times;&nbsp;10<sup>15</sup></p></td><td style="vertical-align:bottom"><p>99.0</p></td></tr><tr><td style="vertical-align:top"><p>18.1 &ndash; 18.5</p></td><td><p>2.04 &times;&nbsp;10<sup>15</sup></p></td><td style="vertical-align:bottom"><p>101.8</p></td></tr><tr><td style="vertical-align:top"><p>18.6 &ndash; 19.0</p></td><td><p>2.09 &times;&nbsp;10<sup>15</sup></p></td><td style="vertical-align:bottom"><p>104.5</p></td></tr><tr><td style="vertical-align:top"><p>19.1 &ndash; 19.5</p></td><td><p>2.15 &times;&nbsp;10<sup>15</sup></p></td><td style="vertical-align:bottom"><p>107.3</p></td></tr><tr><td style="vertical-align:top"><p>19.6 &ndash; 20.0</p></td><td><p>2.20 &times;&nbsp;10<sup>15</sup></p></td><td style="vertical-align:bottom"><p>110.0</p></td></tr><tr><td style="vertical-align:top"><p>20.1 &ndash; 20.5</p></td><td><p>2.26 &times;&nbsp;10<sup>15</sup></p></td><td style="vertical-align:bottom"><p>112.8</p></td></tr><tr><td style="vertical-align:top"><p>20.6 &ndash; 21.0</p></td><td><p>2.31 &times; 10<sup>15</sup></p></td><td style="vertical-align:bottom"><p>115.5</p></td></tr></tbody></table><p><sup>a&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </sup>NOTE: Number of vials per kit and required number of kits is weight-dependent. Dose volume is calculated using the upper limit of the patient weight range.</p><p>&nbsp;</p><p><em><u>Immunomodulatory regimen</u></em></p><p>An immune response to the AAV9&nbsp;capsid will occur after administration of onasemnogene abeparvovec (see section&nbsp;4.4). This can lead to elevations in liver aminotransferases, elevations of troponin I, or decreased platelet counts (see sections&nbsp;4.4 and 4.8). To dampen the immune response immunomodulation with corticosteroids is recommended. Where feasible, the patient&rsquo;s vaccination schedule should be adjusted to accommodate concomitant corticosteroid administration prior to and following onasemnogene abeparvovec infusion (see section&nbsp;4.5).</p><p>&nbsp;</p><p>Prior to initiation of the immunomodulatory regimen and prior to administration of onasemnogene abeparvovec, the patient must be checked for signs and symptoms of active infectious disease of any nature.</p><p>&nbsp;</p><p>Starting 24&nbsp;hours prior to infusion of onasemnogene abeparvovec it is recommended to initiate an immunomodulatory regimen following the schedule below (see Table&nbsp;2). If at any time patients do not respond adequately to the equivalent of 1&nbsp;mg/kg/day oral prednisolone, based on the patient&rsquo;s clinical course, prompt consultation with a paediatric gastroenterologist or hepatologist and adjustment to the recommended immunomodulatory regimen, including increased dose, longer duration or prolongation of corticosteroid taper, should be considered (see section&nbsp;4.4). If oral corticosteroid therapy is not tolerated intravenous corticosteroid may be considered as clinically indicated.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Table&nbsp;2 Pre- and post-infusion immunomodulatory regimen</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Pre-infusion</p></td><td style="vertical-align:top"><p>24&nbsp;hours prior to onasemnogene abeparvovec</p></td><td style="vertical-align:top"><p>Prednisolone orally 1&nbsp;mg/kg/day (or equivalent if another corticosteroid is used)</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p>Post-infusion</p></td><td style="vertical-align:top"><p>30&nbsp;days (including the day of administration of onasemnogene abeparvovec)</p></td><td style="vertical-align:top"><p>Prednisolone orally 1&nbsp;mg/kg/day (or equivalent if another corticosteroid is used)</p></td></tr><tr><td style="vertical-align:top"><p>Followed by 28&nbsp;days:</p><p>&nbsp;</p><p><em>For patients with unremarkable findings (normal clinical exam, total bilirubin, and whose ALT and AST values are both below 2&nbsp;&times;&nbsp;upper&nbsp;limit of normal (ULN) at the end of the 30&nbsp;days period:</em></p><p>&nbsp;</p><p><strong>or</strong></p><p><strong>&nbsp;</strong></p></td><td style="vertical-align:top"><p>Systemic corticosteroids should be tapered gradually.</p><p>&nbsp;</p><p>Tapering of prednisolone (or equivalent if another corticosteroid is used), e.g. 2&nbsp;weeks at 0.5&nbsp;mg/kg/day and then 2&nbsp;weeks at 0.25&nbsp;mg/kg/day oral prednisolone</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>For patients with liver function abnormalities<strong> </strong>at the end of the 30&nbsp;days period: continuing until the AST and ALT values are below 2&nbsp;&times;&nbsp;ULN and all other assessments </em><em>(e.g. total bilirubin) return to normal range, followed by tapering over 28&nbsp;days or longer if needed.</em></p></td><td style="vertical-align:top"><p>Systemic corticosteroids (equivalent to oral prednisolone 1&nbsp;mg/kg/day)</p><p>&nbsp;</p><p>Systemic corticosteroids should be tapered gradually.</p></td></tr></tbody></table><p>Liver function (ALT, AST, total bilirubin) should be monitored at regular intervals for at least 3 months following onasemnogene abeparvovec infusion (weekly in the first month and during the entire corticosteroid taper period, followed by every two weeks for another month), and at other times as clinically indicated. Patients with worsening liver function test results and/or signs or symptoms of acute illness should be promptly clinically assessed and monitored closely (see section 4.4).</p><p>&nbsp;</p><p>If another corticosteroid is used by the physician in place of prednisolone, similar considerations and approach to taper the dose after 30&nbsp;days should be taken as appropriate.</p><p>&nbsp;</p><p><em><u>Special populations</u></em></p><p><em><u>&nbsp;</u></em></p><p><em>Renal impairment</em></p><p>The safety and efficacy of onasemnogene abeparvovec have not been established in patients with renal impairment and onasemnogene abeparvovec therapy should be carefully considered. A dose adjustment should not be considered.</p><p>&nbsp;</p><p><em>Hepatic impairment</em></p><p>Patients with ALT, AST, &nbsp;total bilirubin levels (except due to neonatal jaundice) &gt;2&nbsp;&times;&nbsp;ULN or positive serology for hepatitis B or hepatitis C have not been studied in clinical studies with onasemnogene abeparvovec. Onasemnogene abeparvovec therapy should be carefully considered in patients with hepatic impairment (see sections&nbsp;4.4 and 4.8). A dose adjustment should not be considered.</p><p>&nbsp;</p><p><em>0SMN1/1SMN2 genotype</em></p><p>No dose adjustment should be considered in patients with a bi-allelic mutation of the <em>SMN1</em> gene and only one copy of <em>SMN2</em> (see section&nbsp;5.1).</p><p>&nbsp;</p><p><em>Anti-AAV9&nbsp;antibodies</em></p><p>No dose adjustment should be considered in patients with baseline anti-AAV9&nbsp;antibody titres above 1:50 (see section&nbsp;4.4).</p><p>&nbsp;</p><p><em>Paediatric population</em></p><p>The safety and efficacy of onasemnogene abeparvovec in premature neonates before reaching full-term gestational age have not been established. No data are available. Administration of onasemnogene abeparvovec should be carefully considered because concomitant treatment with corticosteroids may adversely affect neurological development.</p><p>&nbsp;</p><p>There is limited experience in patients 2&nbsp;years of age and older or with body weight above 13.5&nbsp;kg. The safety and efficacy of onasemnogene abeparvovec in these patients have not been established. Currently available data are described in section&nbsp;5.1. A dose adjustment should not be considered (see Table&nbsp;1).</p><p>&nbsp;</p><p><u>Method of administration</u></p><p>&nbsp;</p><p>For intravenous use.</p><p>&nbsp;</p><p>Onasemnogene abeparvovec is administered as a single-dose intravenous infusion. It should be administered with a syringe pump as a single intravenous infusion with a slow infusion of approximately 60&nbsp;minutes. It must not be administered as an intravenous push or bolus.</p><p>&nbsp;</p><p>Insertion of a secondary (&lsquo;back-up&rsquo;) catheter is recommended in case of blockage in the primary catheter. Following completion of infusion, the line should be flushed with sodium chloride 9&nbsp;mg/mL (0.9%) solution for injection.</p><p>&nbsp;</p><p><em>Precautions to be taken before handling or administering the medicinal product</em></p><p>This medicinal product contains a genetically-modified organism. Healthcare professionals should therefore take appropriate precautions (use of gloves, safety goggles, laboratory coat and sleeves) when handling or administering the product (see section&nbsp;6.6).</p><p>&nbsp;</p><p>For detailed instructions on the preparation, handling, accidental exposure and disposal (including proper handling of bodily waste) of onasemnogene abeparvovec, see section&nbsp;6.6.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Traceability</u></p><p>In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded.</p><p>&nbsp;</p><p><u>Pre-existing immunity against AAV9</u></p><p>Anti-AAV9&nbsp;antibody formation can take place after natural exposure. There have been several studies on the prevalence of AAV9&nbsp;antibodies in the general population that show low rates of prior exposure to AAV9 in the paediatric population. Patients should be tested for the presence of AAV9&nbsp;antibodies prior to infusion with onasemnogene abeparvovec. Re-testing may be performed if AAV9&nbsp;antibody titres are reported as above 1:50. It is not yet known whether or under what conditions onasemnogene abeparvovec can be safely and effectively administered in the presence of anti-AAV9&nbsp;antibodies above 1:50 (see sections&nbsp;4.2 and 5.1).</p><p>&nbsp;</p><p><u>Advanced SMA</u></p><p>Since SMA results in progressive and non-reversible damage to motor neurons, the benefit of onasemnogene abeparvovec in symptomatic patients depends on the degree of disease burden at the time of treatment, with earlier treatment resulting in potential higher benefit. While advanced symptomatic SMA patients will not achieve the same gross motor development as unaffected healthy peers they may clinically benefit from gene replacement therapy, dependent on the advancement of disease at the time of treatment (see section&nbsp;5.1).</p><p>&nbsp;</p><p>The treating physician should consider that the benefit is seriously reduced in patients with profound muscle weakness and respiratory failure, patients on permanent ventilation, and patients not able to swallow.</p><p>&nbsp;</p><p>The benefit/risk profile of onasemnogene abeparvovec in patients with advanced SMA, kept alive through permanent ventilation and without the ability to thrive, is not established.</p><p><u>Immunogenicity</u></p><p>An immune response to the AAV9&nbsp;capsid will occur after infusion of onasemnogene abeparvovec, including antibody formation against the AAV9&nbsp;capsid and T cell mediated immune response, despite the immunomodulatory regimen recommended in section&nbsp;4.2, (see also sub‑section &lsquo;<em>Systemic immune response&rsquo;</em> below).</p><p>&nbsp;</p><p><u>Hepatotoxicity</u></p><p>Immune‑mediated hepatotoxicity is generally manifested as elevated ALT and/or AST levels. Acute serious liver injury and acute liver failure, including fatal cases, have been reported with onasemnogene abeparvovec use, typically within 2&nbsp;months after infusion and despite receiving corticosteroids before and after infusion. Immune‑mediated hepatotoxicity may require adjustment of the immunomodulatory regimen including longer duration, increased dose, or prolongation of the corticosteroid taper. (see section&nbsp;4.8).</p><p><u>&nbsp;</u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The risks and benefits of onasemnogene abeparvovec therapy should be carefully considered in patients with pre existing hepatic impairment.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patients with pre existing hepatic impairment or acute hepatic viral infection may be at higher risk of acute serious liver injury (see section 4.2).</p><p>&middot;&nbsp;&nbsp;&nbsp; Data from a small study in children weighing &ge;8.5 kg to &le;21 kg (aged approximately 1.5 to 9 years), indicate a higher frequency of AST or ALT elevations (in 23 out of 24 patients) compared with frequencies of AST/ALT elevations observed in other studies in patients weighing &lt;8.5 kg (in 31 out of 99 patients) (see section 4.8).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Administration of AAV vector often results in aminotransferase elevations.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acute serious liver injury and acute liver failure have occurred with onasemnogene abeparvovec. Cases of acute liver failure with fatal outcome have been reported (see section&nbsp;4.8).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prior to infusion, liver function of all patients should be assessed by clinical examination and laboratory testing (see section&nbsp;4.2).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In order to mitigate potential aminotransferase elevations, a systemic corticosteroid should be administered to all patients before and after onasemnogene abeparvovec infusion (see section&nbsp;4.2).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Liver function should be monitored at regular intervals for at least 3&nbsp;months after infusion, and at other times as clinically indicated (see section 4.2).</p><p>&middot;&nbsp;&nbsp;&nbsp; Patients with worsening liver function test results and/or signs or symptoms of acute illness should be promptly clinically assessed and monitored closely.</p><p>&middot;&nbsp;&nbsp;&nbsp; In case hepatic injury is suspected, prompt consultation with a paediatric gastroenterologist or hepatologist, adjustment of the recommended immunomodulatory regimen and further testing is recommended (e.g. albumin, prothrombin time, PTT, and INR).</p><p>&nbsp;</p><p>AST/ALT/total bilirubin should be assessed weekly for the first month after onasemnogene abeparvovec infusion and during the entire corticosteroid taper period. Tapering of prednisolone should not be considered until AST/ALT levels are less than 2 &times; ULN and all other assessments (e.g. total bilirubin) return to normal range (see section 4.2). If the patient is clinically stable with unremarkable findings at the end of the corticosteroid taper period, liver function should continue to be monitored every two weeks for another month.</p><p><u>Thrombocytopenia</u></p><p>Transient decreases in platelet counts, some of which met the criteria for thrombocytopenia, were observed in onasemnogene abeparvovec clinical studies. In most cases, the lowest platelet value occurred the first week following onasemnogene abeparvovec infusion.</p><p>Post-marketing cases with platelet count &lt;25&nbsp;x&nbsp;10<sup>9</sup>/L have been reported to occur within three weeks following administration.</p><p>Platelet counts should be obtained before onasemnogene abeparvovec infusion and should be closely monitored within the first three weeks following infusion and on a regular basis afterwards, at least weekly for the first month and every other week for the second and third months until platelet counts return to baseline.</p><p>Data from a small study in children weighing &ge;8.5&nbsp;kg to &le;21&nbsp;kg (aged approximately 1.5 to 9&nbsp;years), indicate a higher frequency of thrombocytopenia (in 20 out of 24&nbsp;patients) compared with frequencies of thrombocytopenia observed in other studies in patients weighing &lt;8.5&nbsp;kg (in 22 out of 99&nbsp;patients) (see section&nbsp;4.8).</p><p>&nbsp;</p><p><u>Thrombotic microangiopathy</u></p><p>Several cases of thrombotic microangiopathy (TMA) have been reported with onasemnogene abeparvovec (see section&nbsp;4.8). Cases generally occurred within the first two weeks after onasemnogene abeparvovec infusion. TMA is an acute and life-threatening condition, which is characterised by thrombocytopenia and microangiopathic haemolytic anaemia. Fatal outcomes have been reported. Acute kidney injury has also been observed. In some cases, concurrent immune system activation (e.g. infections, vaccinations) has been reported (see sections&nbsp;4.2 and 4.5 for information on administration of vaccinations).</p><p>Thrombocytopenia is a key feature of TMA, therefore platelet counts should be closely monitored within the first three weeks following infusion and on a regular basis afterwards (see sub-section &lsquo;Thrombocytopenia&rsquo;). In case of thrombocytopenia, further evaluation including diagnostic testing for haemolytic anaemia and renal dysfunction should be undertaken promptly. If patients show clinical signs, symptoms or laboratory findings consistent with TMA, a specialist should be consulted immediately to manage TMA as clinically indicated. Caregivers should be informed about signs and symptoms of TMA and should be advised to seek urgent medical care if such symptoms occur.</p><p>&nbsp;</p><p><u>Elevated troponin‑I</u></p><p>Increases in cardiac troponin‑I levels following infusion with onasemnogene abeparvovec were observed (see section&nbsp;4.8). Elevated troponin-I levels found in some patients may indicate potential myocardial tissue injury. Based on these findings and the observed cardiac toxicity in mice, troponin‑I levels should be obtained before onasemnogene abeparvovec infusion and monitored for at least 3&nbsp;months following onasemnogene abeparvovec infusion or until levels return to within normal reference range for SMA patients. Consider consultation with a cardiac expert as needed.</p><p>&nbsp;</p><p><u>Systemic immune response </u></p><p>Due to the increased risk of serious systemic immune response, it is recommended that patients are clinically stable in their overall health status (e.g. hydration and nutritional status, absence of infection) prior to onasemnogene abeparvovec infusion. Treatment should not be initiated concurrently to active infections, either acute (such&nbsp;as acute respiratory infections or acute hepatitis) or uncontrolled chronic (such as chronic active hepatitis&nbsp;B), until the infection has resolved and the patient is clinically stable (see sections&nbsp;4.2 and 4.4).</p><p>The immunomodulatory regimen (see section&nbsp;4.2) might also impact the immune response to infections (e.g. respiratory), potentially resulting in more severe clinical courses of the infection. Patients with infection were excluded from participation in clinical trials with onasemnogene abeparvovec.. Increased vigilance in the prevention, monitoring and management of infection is recommended before and after onasemnogene abeparvovec infusion. Seasonal prophylactic treatments, that prevent respiratory syncytial virus (RSV) infections, are recommended and should be up to date. Where feasible, the patient&rsquo;s vaccination schedule should be adjusted to accommodate concomitant corticosteroid administration prior to and following onasemnogene abeparvovec infusion (see section&nbsp;4.5).</p><p>If the duration of corticosteroid treatment is prolonged or the dose is increased, the treating physician should be aware of the possibility of adrenal insufficiency.</p><p>&nbsp;</p><p>Risk of tumourigenicity as a result of vector integration</p><p>There is a theoretical risk of tumourigenicity due to integration of AAV vector DNA into the genome.</p><p>Onasemnogene abeparvovec is composed of a non-replicating AAV9 vector whose DNA persists largely in episomal form. Rare instances of random vector integration into human DNA are possible with recombinant AAV. The clinical relevance of individual integration events is unknown, but it is acknowledged that individual integration events could potentially contribute to a risk of tumourigenicity.</p><p>So far, no cases of malignancies associated with onasemnogene abeparvovec treatment have been reported. In the event of a tumour, the marketing authorisation holder should be contacted for guidance on collecting patient samples for testing.</p><p><u>Shedding</u></p><p>Temporary onasemnogene abeparvovec shedding occurs, primarily through bodily waste. Caregivers and patient families should be advised on the following instructions for the proper handling of patient stools:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; good hand-hygiene is required when coming into direct contact with patient bodily waste for a minimum of 1&nbsp;month after onasemnogene abeparvovec treatment.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Disposable nappies can be sealed in double plastic bags and disposed of in household waste.</p><p>&nbsp;</p><p><u>Blood, organ, tissue and cell donation</u></p><p>Patients treated with Zolgensma should not donate blood, organs, tissues or cells for transplantation.</p><p><u>Sodium content</u></p><p>This medicinal product contains 4.6&nbsp;mg sodium per mL, equivalent to 0.23% of the WHO recommended maximum daily intake of 2&nbsp;g sodium for an adult. Each 5.5&nbsp;mL vial contains 25.3&nbsp;mg sodium, and each 8.3&nbsp;mL&nbsp;vial contains 38.2&nbsp;mg sodium.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No interaction studies have been performed.</p><p>&nbsp;</p><p>Experience with use of onasemnogene abeparvovec in patients receiving hepatotoxic medicinal products or using hepatotoxic substances is limited. Safety of onasemnogene abeparvovec in these patients have not been established.</p><p>&nbsp;</p><p>Experience with use of concomitant 5q&nbsp;SMA targeting agents is limited.</p><p>&nbsp;</p><p><em><u>Vaccinations</u></em></p><p>Where feasible, the patient&rsquo;s vaccination schedule should be adjusted to accommodate concomitant corticosteroid administration prior to and following onasemnogene abeparvovec infusion (see sections&nbsp;4.2 and 4.4). Seasonal RSV prophylaxis is recommended (see section&nbsp;4.4). Live vaccines, such as MMR and varicella, should not be administered to patients on an immunosuppressive steroid dose (i.e.,&nbsp;&ge;&nbsp;2&nbsp;weeks of daily receipt of 20&nbsp;mg or 2&nbsp;mg/kg body weight of prednisolone or equivalent).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Human data on use during pregnancy or lactation are not available and animal fertility or reproduction studies have not been performed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Onasemnogene abeparvovec has no or negligible influence on the ability to drive and use machines.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Summary of the safety profile</u></p><p>The safety of onasemnogene abeparvovec was evaluated in 99&nbsp;patients who received onasemnogene abeparvovec at the recommended dose (1.1&nbsp;x&nbsp;10<sup>14</sup>&nbsp;vg/kg) in 5 open-label clinical studies. The most frequently reported adverse reactions following administration were hepatic enzyme increased (24.2%), hepatotoxicity (9.1%), vomiting (8.1%), thrombocytopenia (6.1%), troponin increased (5.1%), and pyrexia (5.1%) (see section&nbsp;4.4).</p><p><u>Tabulated list of adverse reactions</u></p><p>The adverse reactions identified with onasemnogene abeparvovec in all patients treated with intravenous infusion at the recommended dose with a causal association to treatment are presented in Table&nbsp;3. Adverse reactions are classified according to MedDRA system organ classification and frequency. Frequency categories are derived according to the following conventions: very common (&ge;1/10); common (&ge;1/100 to &lt;1/10); uncommon (&ge;1/1,000 to &lt;1/100); rare (&ge;1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000); not known (cannot be estimated from the available data). Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.</p><p>&nbsp;</p><p><strong>Table&nbsp;3</strong><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tabulated list of adverse reactions to onasemnogene abeparvovec</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:98%"><tbody><tr><td colspan="2" style="vertical-align:top"><p><strong>Adverse Reactions by MedDRA SOC/PT and Frequency</strong></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Blood and lymphatic system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Thrombocytopenia<sup>1)</sup></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Thrombotic microangiopathy<sup>2)3)</sup></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Gastrointestinal disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Vomiting</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Hepatobiliary disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Hepatotoxicity<sup>4)</sup></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Acute liver failure<sup>2)3)</sup></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>General disorders and administration site conditions</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Pyrexia</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Investigations</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very common</p></td><td style="vertical-align:top"><p>Hepatic enzyme increased<sup>5)</sup></p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Troponin increased<sup>6)</sup></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><sup>1)</sup>Thrombocytopenia includes thrombocytopenia and platelet count decreased.</p><p><sup>2)</sup>Treatment-related adverse reactions reported outside of pre marketing clinical studies, including in the post‑marketing setting.</p><p><sup>3)</sup>Includes fatal cases.</p><p><sup>4)</sup>Hepatotoxicity includes hepatic steatosis and hypertransaminasaemia.</p><p><sup>5)</sup>Hepatic enzyme increased includes: alanine aminotransferase increased, ammonia increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, hepatic enzyme increased, liver function test increased and transaminases increased.</p><p><sup>6)</sup>Troponin increased includes troponin increased, troponin-T increased, and troponin-I increased (reported outside of clinical studies, including in the post-marketing setting).</p></td></tr></tbody></table><p>&nbsp;</p><p><u>Description of selected adverse reactions</u></p><p>&nbsp;</p><p><em>Hepatobiliary disorders</em></p><p>In the clinical development program (see section 5.1), elevated transaminases &gt;&nbsp;2&nbsp;&times;&nbsp;ULN (and in some cases &gt;&nbsp;20&nbsp;&times;&nbsp;ULN) were observed in 31% of patients treated at the recommended dose. These patients were clinically asymptomatic and none of them had clinically significant elevations of bilirubin. Serum transaminase elevations usually resolved with prednisolone treatment and patients recovered without clinical sequelae (see sections&nbsp;4.2 and 4.4).</p><p>In the post‑marketing setting, there have been reports of children developing signs and symptoms of acute liver failure (e.g. jaundice, coagulopathy, encephalopathy) typically within 2&nbsp;months of treatment with onasemnogene abeparvovec, despite receiving corticosteroids before and after infusion. Cases of acute liver failure with fatal outcome have been reported.</p><p>In a study (COAV101A12306) including 24&nbsp;children weighing &ge;8.5&nbsp;kg to &le;21&nbsp;kg (aged approximately 1.5 to 9&nbsp;years; 21 discontinued previous SMA treatment) increased transaminases were observed in 23 out of 24&nbsp;patients. The patients were asymptomatic and there were no elevations of bilirubin. The AST and ALT elevations were managed with the use of corticosteroids, typically with prolonged duration (at Week&nbsp;26, 17&nbsp;patients were continuing prednisolone, at Week&nbsp;52, 6&nbsp;patients were still receiving prednisolone) and/or a higher dose.</p><p><em>Transient thrombocytopenia</em></p><p>In the clinical development program (see section 5.1), transient thrombocytopenia was observed at multiple time points post-dose and normally resolved within two weeks. Decreases in platelet counts were more prominent during the first week of treatment Post-marketing cases with transient decrease in platelet count to levels &lt;25&nbsp;x&nbsp;10<sup>9</sup>/L within three weeks of administration have been reported (see section&nbsp;4.4).</p><p>In a study (COAV101A12306) including 24&nbsp;children weighing &ge;8.5&nbsp;kg to &le;21&nbsp;kg (aged approximately 1.5 to 9&nbsp;years), thrombocytopenia was observed in 20 out of 24&nbsp;patients.</p><p>&nbsp;</p><p><em>Increases in troponin-I levels</em></p><p>Increases in cardiac troponin-I levels up to 0.2&nbsp;mcg/L following onasemnogene abeparvovec infusion were observed. In the clinical study program, there were no clinically apparent cardiac findings observed following administration of onasemnogene abeparvovec (see&nbsp;section&nbsp;4.4).</p><p>&nbsp;</p><p><em>Immunogenicity</em></p><p>Pre- and post-gene therapy titres of anti-AAV9&nbsp;antibodies were measured in the clinical studies (see section&nbsp;4.4). All patients that received onasemnogene abeparvovec had anti-AAV9&nbsp;titres at or below&nbsp;1:50 before treatment. Mean increases from baseline in AAV9&nbsp;titre were observed in all patients at all but 1&nbsp;time-point for antibody titre levels to AAV9&nbsp;peptide, reflecting normal response to non‑self viral antigen. Some patients experienced AAV9&nbsp;titres exceeding the level of quantification, however most of these patients did not have potentially clinically significant adverse reactions. Thus, no relationship has been established between high anti-AAV9&nbsp;antibody&nbsp;titres and the potential for adverse reactions or efficacy parameters.</p><p>In the AVXS-101-CL-101 clinical study, 16&nbsp;patients were screened for anti-AAV9&nbsp;antibody&nbsp;titre: 13&nbsp;had titres less than 1:50 and were enrolled in the study; three patients had titres greater than 1:50, two of whom were retested following cessation of breast-feeding and their titres were measured at less than 1:50 and both were enrolled in the study. There is no information on whether breastfeeding should be restricted in mothers who may be seropositive for anti-AAV9 antibodies. Patients all had less than or equal to 1:50 AAV9&nbsp;antibody&nbsp;titre prior to treatment with onasemnogene abeparvovec and subsequently demonstrated an increase in anti-AAV9&nbsp;antibody&nbsp;titres to at least 1:102,400 and up to greater than 1:819,200.</p><p>The detection of antibody formation is highly dependent on the sensitivity and specificity of the assay. In addition, the observed incidence of antibody (including neutralising antibody) positivity in an assay may be influenced by several factors including assay methodology, sample handling, timing of sample collection, concomitant medicinal products and underlying disease.</p><p>No onasemnogene abeparvovec-treated patient demonstrated an immune response to the transgene.</p><p>&nbsp;</p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions.</p><p><strong>&nbsp;</strong></p><p><strong>-<em>To reports any side effect(s): </em></strong></p><p>&middot;&nbsp;&nbsp;&nbsp; <strong><em>Saudi Arabia: </em></strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Saudi Food and Drug Authority National Pharmacovigilance Center (NPC):</p><p>o SFDA call center: 19999</p><p>o E-mail: npc.drug@sfda.gov.sa</p><p>o Website: https://ade.sfda.gov.sa</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patient Safety Department Novartis Consulting AG - Saudi Arabia:</p><p>O Toll Free Number: 8001240078<br />O Phone: +966112658100<br />O Fax: +966112658107<br />O Email: adverse.events@novartis.com</p><p>&middot;&nbsp;&nbsp;&nbsp; <strong><em>Other GCC States: </em></strong></p><p>- Please contact the relevant competent authority.</p><p><strong>To report any complaint(s) :</strong> complaints.ksa@novartis.com</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No data from clinical studies are available regarding overdose of onasemnogene abeparvovec. Adjustment of the dose of prednisolone, close clinical observation and monitoring of laboratory parameters (including clinical chemistry and haematology) for systemic immune response are recommended (see section&nbsp;4.4).</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Other drugs for disorders of the musculo-skeletal system, ATC code: M09AX09</p><p>&nbsp;</p><p><u>Mechanism of action</u></p><p>Onasemnogene abeparvovec is a gene therapy designed to introduce a functional copy of the survival motor neuron gene (<em>SMN1</em>) in the transduced cells to address the monogenic root cause of the disease. By providing an alternative source of SMN protein expression in motor neurons, it is expected to promote the survival and function of transduced motor neurons.</p><p>&nbsp;</p><p>Onasemnogene abeparvovec is a non-replicating recombinant AAV vector that utilizes AAV9&nbsp;capsid to deliver a stable, fully functional human SMN transgene. The ability of the AAV9&nbsp;capsid to cross the blood brain barrier and transduce motor neurons has been demonstrated. The <em>SMN1</em> gene present in onasemnogene abeparvovec is designed to reside as episomal DNA in the nucleus of transduced cells and is expected to be stably expressed for an extended period of time in post-mitotic cells. The AAV9&nbsp;virus is not known to cause disease in humans. The transgene is introduced to target cells as a self‑complementary double‑stranded molecule. Expression of the transgene is driven by a constitutive promoter (cytomegalovirus enhanced chicken-&beta;‑actin-hybrid), which results in continuous and sustained SMN protein expression. Proof of the mechanism of action has been supported by non-clinical studies and by human biodistribution data.</p><p>&nbsp;</p><p><u>Clinical efficacy and safety</u></p><p>&nbsp;</p><p><em>AVXS-101-CL-303 Phase&nbsp;3 study in patients with Type&nbsp;1 SMA</em></p><p>&nbsp;</p><p>AVXS-101-CL-303 (Study&nbsp;CL-303) is a Phase&nbsp;3 open-label, single-arm, single-dose study of intravenous administration of onasemnogene abeparvovec at the therapeutic dose (1.1&nbsp;&times;&nbsp;10<sup>14</sup>&nbsp;vg/kg). Twenty-two patients were enrolled with Type&nbsp;1&nbsp;SMA and 2&nbsp;copies of <em>SMN2</em>. Before treatment with onasemnogene abeparvovec, none of the 22&nbsp;patients required non-invasive ventilator (NIV) support, and all patients could exclusively feed orally (i.e., did not need non‑oral nutrition). The mean Children&rsquo;s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP‑INTEND) score at baseline was 32.0 (range, 18 to 52). The mean age of the 22&nbsp;patients at the time of treatment was 3.7&nbsp;months (0.5 to 5.9&nbsp;months).</p><p>&nbsp;</p><p>Of the 22 enrolled patients, 21&nbsp;patients survived without permanent ventilation (i.e., event-free survival) to &ge;10.5&nbsp;months of age, 20&nbsp;patients survived to &ge;14&nbsp;months of age (co-primary efficacy endpoint), and 20&nbsp;patients survived event-free to 18&nbsp;months of age.</p><p>&nbsp;</p><p>Three patients did not complete the study, of which 2&nbsp;patients had an event (death or permanent ventilation) leading to 90.9% (95% CI: 79.7%, 100.0%) event-free survival (alive without permanent ventilation) at 14&nbsp;months of age, see Figure&nbsp;1.</p><p>&nbsp;</p><p><strong>Figure&nbsp;1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>Time (months) to death or permanent ventilation </strong><strong>pooled from </strong><strong>onasemnogene abeparvovec </strong><strong>IV studies (CL-101, CL-302, CL-303, CL-304-2 copy cohort)</strong></p><p><!--[if gte vml 1]><v:shapetype
 id="_x0000_t202" coordsize="21600,21600" o:spt="202" path="m,l,21600r21600,l21600,xe">
 <v:stroke joinstyle="miter"/>
 <v:path gradientshapeok="t" o:connecttype="rect"/>
</v:shapetype><v:shape id="Text_x0020_Box_x0020_23" o:spid="_x0000_s1034"
 type="#_x0000_t202" style='position:absolute;margin-left:185.95pt;
 margin-top:-.05pt;width:152.05pt;height:19.45pt;z-index:251661824;
 visibility:visible;mso-height-relative:margin' o:gfxdata="UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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" filled="f" stroked="f" strokeweight=".5pt"/><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p>&nbsp;</p></td></tr></tbody></table></td></tr></tbody></table><p><img alt="" width="1071" height="644" src="data:image/png;base64,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" /></p><p>&nbsp;</p><p>PNCR = Pediatric Neuromuscular Clinical Research natural history cohort</p><p>NeuroNext = Network for Excellence in Neuroscience Clinical Trials natural history cohort</p><p>&nbsp;</p><p>For the 14&nbsp;patients in Study CL-303 that achieved the milestone of independent sitting for at least 30&nbsp;seconds at any visit during the study, the median age when this milestone was first demonstrated was 12.6&nbsp;months (range: 9.2 to 18.6&nbsp;months). Thirteen patients (59.1%) confirmed the milestone of independent sitting for at least 30&nbsp;seconds at the 18‑month visit (co-primary endpoint, p&lt;0.0001). One patient achieved the milestone of sitting independently for 30&nbsp;seconds at 16&nbsp;months of age, but this milestone was not confirmed at the Month&nbsp;18 visit. The video-confirmed developmental milestones for patients in Study CL-303 are summarised in Table&nbsp;4. Three patients did not achieve any motor milestones (13.6%) and another 3&nbsp;patients (13.6%) achieved head control as the maximum motor milestone before the 18&nbsp;months of age final study visit.</p><p>&nbsp;</p><p><strong>Table&nbsp;</strong><strong>4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Median time to video documented achievement of motor milestones Study CL-303</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p>Video documented milestone</p></td><td style="vertical-align:top"><p>Number of patients achieving milestone</p><p>n/N (%)</p></td><td style="vertical-align:top"><p>Median age to the milestone achievement</p><p>(months)</p></td><td style="vertical-align:top"><p>95%&nbsp;Confidence interval</p></td></tr><tr><td style="vertical-align:top"><p>Head control</p></td><td style="vertical-align:top"><p>17/20* (85.0)</p></td><td style="vertical-align:top"><p>6.8</p></td><td style="vertical-align:top"><p>(4.77, 7.57)</p></td></tr><tr><td style="vertical-align:top"><p>Rolls from back to sides</p></td><td style="vertical-align:top"><p>13/22 (59.1)</p></td><td style="vertical-align:top"><p>11.5</p></td><td style="vertical-align:top"><p>(7.77, 14.53)</p></td></tr><tr><td style="vertical-align:top"><p>Sits without support for 30&nbsp;seconds (Bayley)</p></td><td style="vertical-align:top"><p>14/22 (63.6)</p></td><td style="vertical-align:top"><p>12.5</p></td><td style="vertical-align:top"><p>(10.17, 15.20)</p></td></tr><tr><td style="vertical-align:top"><p>Sitting without support for at least 10&nbsp;seconds (WHO)</p></td><td style="vertical-align:top"><p>14/22 (63.6)</p></td><td style="vertical-align:top"><p>13.9</p></td><td style="vertical-align:top"><p>(11.00, 16.17)</p></td></tr></tbody></table><p>* 2&nbsp;patients were reported to have Head Control by clinician assessment at baseline.</p><p>&nbsp;</p><p>One patient (4.5%) could also walk with assistance at 12.9&nbsp;months. Based on the natural history of the disease, patients who met the study entry criteria would not be expected to attain the ability to sit without support. In addition, 18 of the 22&nbsp;patients were independent of ventilatory support at 18&nbsp;months of age.</p><p>&nbsp;</p><p>Motor function improvements were also observed as measured by the CHOP-INTEND, see Figure&nbsp;2. Twenty-one patients (95.5%) achieved a CHOP-INTEND score &ge;&nbsp;40, 14&nbsp;patients (63.6%) had achieved a CHOP-INTEND score &ge;&nbsp;50, and 9&nbsp;patients (40.9%) had achieved a CHOP-INTEND score &ge;&nbsp;58. Patients with untreated SMA&nbsp;Type&nbsp;1 almost never achieve a CHOP-INTEND score &ge;&nbsp;40. Motor milestone achievement was observed in some patients despite plateauing of CHOP-INTEND. No clear correlation was observed between CHOP-INTEND scores and motor milestone achievement.</p><p>&nbsp;</p><p><strong>Figure</strong><strong>&nbsp;</strong><strong>2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong> </strong><strong>CHOP-INTEND motor function scores - Study&nbsp;CL-303 (N=22)</strong></p><p><!--[if gte vml 1]><v:shape id="Text_x0020_Box_x0020_14"
 o:spid="_x0000_s1027" type="#_x0000_t202" style='position:absolute;left:0;
 text-align:left;margin-left:165.9pt;margin-top:204pt;width:83.35pt;height:19.95pt;
 text-indent:0;z-index:251654656;visibility:visible' o:gfxdata="UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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" filled="f" stroked="f" strokeweight=".5pt"/><![endif]--></p><table cellpadding="0" cellspacing="0"><tbody><tr><td><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p>Age (months)</p></td></tr></tbody></table></td></tr></tbody></table><p><img alt="" width="927" height="453" src="data:image/png;base64,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" /></p><p>&nbsp;</p><p>&nbsp;</p><p><em>AVXS-101-CL-302 Phase&nbsp;3 study in patients with Type&nbsp;1 SMA</em></p><p><em>&nbsp;</em></p><p>AVXS-101-CL-302 (Study CL-302) is a Phase&nbsp;3, open-label, single-arm, single-dose study of intravenous administration of onasemnogene abeparvovec at the therapeutic dose (1.1&nbsp;&times;&nbsp;10<sup>14</sup>&nbsp;vg/kg). Thirty-three patients were enrolled with Type&nbsp;1 SMA and 2&nbsp;copies of <em>SMN2</em>. Before treatment with onasemnogene abeparvovec, 9&nbsp;patients (27.3%) reported ventilatory support and 9&nbsp;patients (27.3%) reported feeding support. The mean CHOP‑INTEND score of the 33&nbsp;patients at baseline was 27.9 (range, 14 to 55). The mean age of the 33&nbsp;patients at the time of treatment was 4.1&nbsp;months (range, 1.8 to 6.0&nbsp;months).</p><p>&nbsp;</p><p>Of the 33 enrolled patients (Efficacy Completers population), one patient (3%) was dosed outside of protocol age range and was therefore not included in the intent-to-treat (ITT) population. Of the 32&nbsp;patients in the ITT population, one patient (3%) died during the study, due to disease progression.</p><p>&nbsp;</p><p>Of the 32&nbsp;patients in the ITT population, 14&nbsp;patients (43.8%) achieved the milestone of sitting without support for at least 10&nbsp;seconds at any visit up to and including the 18&nbsp;month visit (primary efficacy endpoint). The median age when this milestone was first achieved was 15.9&nbsp;months (range, 7.7 to 18.6&nbsp;months). Thirty-one patients (96.9%) in the ITT population survived without permanent ventilation (i.e., event-free survival) to &ge;&nbsp;14&nbsp;months of age (secondary efficacy endpoint).</p><p>&nbsp;</p><p>The additional video-confirmed developmental milestones for patients in the Efficacy Completers population in Study CL-302 at any visit up to and including the 18&nbsp;month visit are summarised in Table&nbsp;5.</p><p>&nbsp;</p><p><strong>Table&nbsp;5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Median time to video documented achievement of motor milestones in Study CL-302 (Efficacy Completers population)</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p>Video documented milestone</p></td><td style="vertical-align:top"><p>Number of patients achieving milestone</p><p>n/N (%)</p></td><td style="vertical-align:top"><p>Median age to the milestone achievement</p><p>(months)</p></td><td style="vertical-align:top"><p>95%&nbsp;Confidence interval</p></td></tr><tr><td style="vertical-align:top"><p>Head control</p></td><td style="vertical-align:top"><p>23/30* (76.7)</p></td><td style="vertical-align:top"><p>8.0</p></td><td style="vertical-align:top"><p>(5.8, 9.2)</p></td></tr><tr><td style="vertical-align:top"><p>Rolls from back to sides</p></td><td style="vertical-align:top"><p>19/33 (57.6)</p></td><td style="vertical-align:top"><p>15.3</p></td><td style="vertical-align:top"><p>(12.5, 17.4)</p></td></tr><tr><td style="vertical-align:top"><p>Sits without support for at least 30&nbsp;seconds</p></td><td style="vertical-align:top"><p>16/33 (48.5)</p></td><td style="vertical-align:top"><p>14.3</p></td><td style="vertical-align:top"><p>(8.3, 18.3)</p></td></tr></tbody></table><p>* 3&nbsp;patients were reported to have head control by clinician assessment at baseline.</p><p>&nbsp;</p><p>One patient (3%) achieved the motor milestones of crawling, standing with assistance, stands alone, walking with assistance, and walking alone all by the age of 18&nbsp;months.</p><p>&nbsp;</p><p>Of the 33 enrolled patients, 24&nbsp;patients (72.7%) achieved a CHOP-INTEND score &ge;&nbsp;40, 14&nbsp;patients (42.4%) achieved a CHOP-INTEND score &ge;&nbsp;50, and 3&nbsp;patients (9.1%) achieved a CHOP-INTEND score &ge;&nbsp;58 (see Figure&nbsp;3). Patients with untreated SMA Type&nbsp;1 almost never achieve a CHOP‑INTEND score &ge;&nbsp;40.</p><p>&nbsp;</p><p><strong>Figure</strong><strong>&nbsp;</strong><strong>3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CHOP-INTEND motor function scores in Study&nbsp;CL-302 (Efficacy Completers population; N=33)*</strong></p><p><!--[if gte vml 1]><v:shape
 id="Text_x0020_Box_x0020_4" o:spid="_x0000_s1029" type="#_x0000_t202" style='position:absolute;
 left:0;text-align:left;margin-left:188.6pt;margin-top:196.2pt;width:89.7pt;
 height:17.75pt;z-index:251656704;visibility:visible' o:gfxdata="UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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" stroked="f" strokeweight="0">
 <v:textbox inset="0,0,0,0"/>
</v:shape><![endif]--></p><table cellpadding="0" cellspacing="0"><tbody><tr><td><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p>Age (Months)</p></td></tr></tbody></table></td></tr></tbody></table><p>&nbsp;</p><p><img alt="" width="1078" height="423" src="data:image/png;base64,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" /></p><p>&nbsp;</p><p>*Note: The total score programmatically calculated for one patient&nbsp;at Month&nbsp;7 (total score=3) is considered invalid. All items were not scored and the total score should have been set to Missing (i.e. not calculated).</p><p><em>&nbsp;</em></p><p><em>AVXS-101-CL-101 Phase&nbsp;1 study in patients with Type&nbsp;1 SMA</em></p><p>&nbsp;</p><p>The results seen in Study CL-303 are supported by study AVXS-101-CL-101 (Study CL-101) a phase&nbsp;1 study in patients with Type&nbsp;1 SMA, in which onasemnogene abeparvovec was administered as a single intravenous infusion in 12&nbsp;patients from 3.6&nbsp;kg to 8.4&nbsp;kg (0.9 to 7.9&nbsp;months of age). At 14&nbsp;months of age, all treated patients were event-free; i.e.&nbsp;survived without permanent ventilation, compared to 25% in the natural history cohort. At the end of the study (24&nbsp;months post-dose), all treated patients were event-free, compared to less than 8% in the natural history, see Figure&nbsp;1.</p><p>&nbsp;</p><p>At 24&nbsp;months of follow up post-dose, 10 out of 12&nbsp;patients were able to sit without support for &ge;&nbsp;10&nbsp;seconds, 9&nbsp;patients were able to sit without support for &ge;&nbsp;30&nbsp;seconds and 2&nbsp;patients were able to stand and walk without assistance. One out of 12&nbsp;patients did not achieve head control as the maximum motor milestone before the age of 24&nbsp;months. Ten of 12&nbsp;patients from Study&nbsp;CL‑101 continue to be followed in a long-term study (for up to 6.6&nbsp;years after dosing) and all 10&nbsp;patients were alive and free of permanent ventilation as of 23 May 2021. All patients have either maintained previously attained milestones or gained new milestones such as sitting with support, standing with assistance and walking alone. Five of the 10&nbsp;patients received concomitant nusinersen or risdiplam treatment at some point during the long-term study. Maintenance of efficacy and achievement of milestones can therefore not be solely attributed to onasemnogene abeparvovec in all patients. The milestone of standing with assistance was newly acquired by 2&nbsp;patients who had not received nusinersen or risdiplam at any point prior to the time this milestone was achieved.</p><p>&nbsp;</p><p><em>AVXS-101-CL-304 Phase&nbsp;3 study in patients with pre-symptomatic SMA</em></p><p><em>&nbsp;</em></p><p>Study CL‑304 is a global, Phase&nbsp;3, open-label, single-arm, single-dose study of intravenous administration of onasemnogene abeparvovec in pre-symptomatic newborn patients up to 6&nbsp;weeks of age with 2&nbsp;(cohort&nbsp;1,&nbsp;n=14) or 3&nbsp;(cohort&nbsp;2,&nbsp;n=15) copies of <em>SMN2</em>.</p><p>&nbsp;</p><p>Cohort&nbsp;1</p><p>The 14 treated patients with 2&nbsp;copies of <em>SMN2</em> were followed to 18&nbsp;months of age. All patients survived event-free to &ge;&nbsp;14&nbsp;months of age without permanent ventilation.</p><p>&nbsp;</p><p>All 14&nbsp;patients achieved independent sitting for at least 30&nbsp;seconds at any visit up to the 18&nbsp;months of age visit (primary efficacy endpoint), at ages ranging from 5.7 to 11.8&nbsp;months, with 11 of the 14&nbsp;patients who achieved independent sitting at or before 279&nbsp;days of age, the 99th&nbsp;percentile for development of this milestone. Nine patients achieved the milestone of walking alone (64.3%). All 14&nbsp;patients achieved a CHOP-INTEND score &ge;&nbsp;58 at any visit up to the 18&nbsp;months of age visit. No patients required any ventilatory support or any feeding support during the study.</p><p>&nbsp;</p><p>Cohort&nbsp;2</p><p>The 15 treated patients with 3&nbsp;copies of <em>SMN2 </em>were followed to 24&nbsp;months of age. All patients survived event-free to 24&nbsp;months of age without permanent ventilation.</p><p>&nbsp;</p><p>All 15&nbsp;patients were able to stand alone without support for at least 3&nbsp;seconds (primary efficacy endpoint), at ages ranging from 9.5 to 18.3&nbsp;months, with 14 of the 15&nbsp;patients who achieved standing alone at or before 514&nbsp;days of age, the 99th percentile for development of this milestone. Fourteen patients (93.3%) were able to walk at least five steps independently. All 15&nbsp;patients achieved a scaled score of &ge;&nbsp;4 on Bayley-III Gross and Fine Motor Subtests within 2 standard deviations of the mean for age at any post-baseline visit up to 24&nbsp;months of age. No patients required any ventilatory support or any feeding support during the study.</p><p>&nbsp;</p><p>Onasemnogene abeparvovec has not been studied in patients with a bi-allelic mutation of the <em>SMN1</em>&nbsp;gene and only one copy of <em>SMN2</em> in clinical studies.</p><p>&nbsp;</p><p>The European Medicines Agency has deferred the obligation to submit the results of studies with onasemnogene abeparvovec in one or more subsets of the paediatric population in spinal muscular atrophy for the granted indication (see section&nbsp;4.2 for information on paediatric use).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Onasemnogene abeparvovec vector shedding studies, which assess the amount of vector eliminated from the body through saliva, urine and faeces were performed.</p><p>&nbsp;</p><p>Onasemnogene abeparvovec was detectable in shedding samples post-infusion. Clearance of onasemnogene abeparvovec was primarily via faeces and the majority is cleared within 30&nbsp;days after dose administration.</p><p>&nbsp;</p><p>Biodistribution was evaluated in 2&nbsp;patients who died 5.7&nbsp;months and 1.7&nbsp;months, respectively, after infusion of onasemnogene abeparvovec at the dose of 1.1&nbsp;x&nbsp;10<sup>14</sup>&nbsp;vg/kg. Both cases showed that the highest levels of vector DNA were found in the liver. Vector DNA was also detected in the spleen, heart, pancreas, inguinal lymph node, skeletal muscles, peripheral nerves, kidney, lung, intestines, gonads, spinal cord, brain, and thymus. Immunostaining for SMN protein showed generalized SMN expression in spinal motor neurons, neuronal and glial cells of the brain, and in the heart, liver, skeletal muscles, and other tissues evaluated.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Following intravenous administration in neonatal mice, vector was widely distributed, with the highest vector DNA levels generally detected in the heart, liver, lungs and skeletal muscle. The expression of transgene mRNA showed similar patterns. Following intravenous administration in juvenile non‑human primates, vector was widely distributed with subsequent expression of transgene mRNA, with the highest concentrations of vector DNA and transgene mRNA tending to occur in the liver, muscle, and heart. Vector DNA and transgene mRNA in both species was detected in the spinal cord, brain, and gonads.</p><p>&nbsp;</p><p>In pivotal 3‑month mouse toxicology studies, the main target organs of toxicity identified were the heart and liver. Onasemnogene abeparvovec-related findings in the ventricles of the heart were comprised of dose-related inflammation, oedema and fibrosis. In the atria of the heart, inflammation, thrombosis, myocardial degeneration/necrosis and fibroplasia were observed. A No Adverse Effect Level (NoAEL) was not identified for onasemnogene abeparvovec in mouse studies as ventricular myocardial inflammation/oedema/fibrosis and atrial inflammation were observed at the lowest dose tested (1.5&nbsp;&times;&nbsp;10<sup>14</sup>&nbsp;vg/kg). This dose is regarded as the Maximum Tolerated Dose and approximately 1.4&shy;‑fold the recommended clinical dose. Onasemnogene abeparvovec-related mortality was, in the majority of mice, associated with atrial thrombosis, and observed at 2.4 &times; 10<sup>14</sup>&nbsp;vg/kg. The cause of the mortality in the rest of the animals was undetermined, although microscopic degeneration/regeneration in the hearts of these animals was found.</p><p>&nbsp;</p><p>Liver findings in mice were comprised of hepatocellular hypertrophy, Kupffer cell activation, and scattered hepatocellular necrosis. In long-term toxicity studies with intravenous and intrathecal (not indicated for use) administration of onasemnogene abeparvovec in juvenile non-human primates, liver findings, including single cell necrosis of hepatocytes and oval cell hyperplasia, demonstrated partial (IV) or complete (IT) reversibility.</p><p>&nbsp;</p><p>In a 6-month toxicology study conducted in juvenile non-human primates, administration of a single dose of onasemnogene abeparvovec at the clinically recommended intravenous dose, with or without corticosteroid treatment, resulted in acute, minimal to slight mononuclear cell inflammation and neuronal degeneration in the dorsal root ganglia (DRG) and trigeminal ganglia (TG), as well as axonal degeneration and/or gliosis in the spinal cord. At 6&nbsp;months, these non-progressive findings resulted in full resolution in the TG, and partial resolution (decreased incidence and/or severity) in the DRG and spinal cord. Following intrathecal administration of onasemnogene abeparvovec (not indicated for use), these acute, non-progressive findings were noted with minimal to moderate severity in juvenile non-human primates with partial to full resolution at 12&nbsp;months. These findings in non-human primates had no correlative clinical observations, therefore the clinical relevance in humans is unknown.</p><p>&nbsp;</p><p>Genotoxicity, carcinogenicity and reproduction toxicity studies have not been conducted with onasemnogene abeparvovec.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>Tromethamine</p><p>Magnesium chloride</p><p>Sodium chloride</p><p>Poloxamer&nbsp;188</p><p>Hydrochloric acid (for pH adjustment)</p><p>Water for injections</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the absence of compatibility studies, this medicinal product should not be mixed with other medicinal products.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                1 years

After thawing
Once thawed, the medicinal product should not be re-frozen and may be stored refrigerated at 2°C to 8°C in the original carton for 14 days.

Once the dose volume is drawn into the syringe it must be infused within 8 hours. Discard the vector containing syringe if not infused within the 8 hour timeframe.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store and transport frozen (&le; - 60&deg;C).</p><p>Store in a refrigerator (2&deg;C to 8&deg;C) immediately upon receipt.</p><p>Store in the original carton.</p><p>For storage conditions after thawing of the medicinal product, see section 6.3.</p><p>The date of receipt should be marked on the original carton before the product is stored in the refrigerator.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Onasemnogene abeparvovec is supplied in a vial (10&nbsp;mL polymer crystal zenith) with stopper (20&nbsp;mm chlorobutyl rubber) and seal (aluminum, flip-off) with a coloured cap (plastic), in two different vial fill volume sizes, either 5.5&nbsp;mL or 8.3&nbsp;mL.</p><p>&nbsp;</p><p>The dose of onasemnogene abeparvovec and exact number of vials required for each patient is calculated according to the patient&rsquo;s weight (see section&nbsp;4.2 and Table&nbsp;6 below).</p><p>&nbsp;</p><p><strong>Table&nbsp;</strong><strong>6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Carton/kit configurations</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:624px"><thead><tr><td><p><strong>Patient weight&nbsp;(kg)</strong></p></td><td><p><strong>5.5&nbsp;mL&nbsp;vial<sup>a</sup></strong></p></td><td><p><strong>8.3&nbsp;mL&nbsp;vial<sup>b</sup></strong></p></td><td><p><strong>Total vials per carton</strong></p></td></tr></thead><tbody><tr><td><p>2.6 &ndash; 3.0</p></td><td><p>0</p></td><td><p>2</p></td><td><p>2</p></td></tr><tr><td><p>3.1 &ndash; 3.5</p></td><td><p>2</p></td><td><p>1</p></td><td><p>3</p></td></tr><tr><td><p>3.6 &ndash; 4.0</p></td><td><p>1</p></td><td><p>2</p></td><td><p>3</p></td></tr><tr><td><p>4.1 &ndash; 4.5</p></td><td><p>0</p></td><td><p>3</p></td><td><p>3</p></td></tr><tr><td><p>4.6 &ndash; 5.0</p></td><td><p>2</p></td><td><p>2</p></td><td><p>4</p></td></tr><tr><td><p>5.1 &ndash; 5.5</p></td><td><p>1</p></td><td><p>3</p></td><td><p>4</p></td></tr><tr><td><p>5.6 &ndash; 6.0</p></td><td><p>0</p></td><td><p>4</p></td><td><p>4</p></td></tr><tr><td><p>6.1 &ndash; 6.5</p></td><td><p>2</p></td><td><p>3</p></td><td><p>5</p></td></tr><tr><td><p>6.6 &ndash; 7.0</p></td><td><p>1</p></td><td><p>4</p></td><td><p>5</p></td></tr><tr><td><p>7.1 &ndash; 7.5</p></td><td><p>0</p></td><td><p>5</p></td><td><p>5</p></td></tr><tr><td><p>7.6 &ndash; 8.0</p></td><td><p>2</p></td><td><p>4</p></td><td><p>6</p></td></tr><tr><td><p>8.1 &ndash; 8.5</p></td><td><p>1</p></td><td><p>5</p></td><td><p>6</p></td></tr><tr><td><p>8.6 &ndash; 9.0</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>6</p></td><td style="vertical-align:top"><p>6</p></td></tr><tr><td><p>9.1 &ndash; 9.5</p></td><td style="vertical-align:top"><p>2</p></td><td style="vertical-align:top"><p>5</p></td><td style="vertical-align:top"><p>7</p></td></tr><tr><td><p>9.6 &ndash; 10.0</p></td><td style="vertical-align:top"><p>1</p></td><td style="vertical-align:top"><p>6</p></td><td style="vertical-align:top"><p>7</p></td></tr><tr><td><p>10.1 &ndash; 10.5</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>7</p></td><td style="vertical-align:top"><p>7</p></td></tr><tr><td><p>10.6 &ndash; 11.0</p></td><td style="vertical-align:top"><p>2</p></td><td style="vertical-align:top"><p>6</p></td><td style="vertical-align:top"><p>8</p></td></tr><tr><td><p>11.1 &ndash; 11.5</p></td><td style="vertical-align:top"><p>1</p></td><td style="vertical-align:top"><p>7</p></td><td style="vertical-align:top"><p>8</p></td></tr><tr><td><p>11.6 &ndash; 12.0</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>8</p></td><td style="vertical-align:top"><p>8</p></td></tr><tr><td><p>12.1 &ndash; 12.5</p></td><td style="vertical-align:top"><p>2</p></td><td style="vertical-align:top"><p>7</p></td><td style="vertical-align:top"><p>9</p></td></tr><tr><td><p>12.6 &ndash; 13.0</p></td><td style="vertical-align:top"><p>1</p></td><td style="vertical-align:top"><p>8</p></td><td style="vertical-align:top"><p>9</p></td></tr><tr><td><p>13.1 &ndash; 13.5</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>9</p></td><td style="vertical-align:top"><p>9</p></td></tr><tr><td style="vertical-align:top"><p>13.6 &ndash; 14.0</p></td><td style="vertical-align:top"><p>2</p></td><td style="vertical-align:top"><p>8</p></td><td style="vertical-align:top"><p>10</p></td></tr><tr><td style="vertical-align:top"><p>14.1 &ndash; 14.5</p></td><td style="vertical-align:top"><p>1</p></td><td style="vertical-align:top"><p>9</p></td><td style="vertical-align:top"><p>10</p></td></tr><tr><td style="vertical-align:top"><p>14.6 &ndash; 15.0</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>10</p></td><td style="vertical-align:top"><p>10</p></td></tr><tr><td style="vertical-align:top"><p>15.1 &ndash; 15.5</p></td><td style="vertical-align:top"><p>2</p></td><td style="vertical-align:top"><p>9</p></td><td style="vertical-align:top"><p>11</p></td></tr><tr><td style="vertical-align:top"><p>15.6 &ndash; 16.0</p></td><td style="vertical-align:top"><p>1</p></td><td style="vertical-align:top"><p>10</p></td><td style="vertical-align:top"><p>11</p></td></tr><tr><td style="vertical-align:top"><p>16.1 &ndash; 16.5</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>11</p></td><td style="vertical-align:top"><p>11</p></td></tr><tr><td style="vertical-align:top"><p>16.6 &ndash; 17.0</p></td><td style="vertical-align:top"><p>2</p></td><td style="vertical-align:top"><p>10</p></td><td style="vertical-align:top"><p>12</p></td></tr><tr><td style="vertical-align:top"><p>17.1 &ndash; 17.5</p></td><td style="vertical-align:top"><p>1</p></td><td style="vertical-align:top"><p>11</p></td><td style="vertical-align:top"><p>12</p></td></tr><tr><td style="vertical-align:top"><p>17.6 &ndash; 18.0</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>12</p></td><td style="vertical-align:top"><p>12</p></td></tr><tr><td style="vertical-align:top"><p>18.1 &ndash; 18.5</p></td><td style="vertical-align:top"><p>2</p></td><td style="vertical-align:top"><p>11</p></td><td style="vertical-align:top"><p>13</p></td></tr><tr><td style="vertical-align:top"><p>18.6 &ndash; 19.0</p></td><td style="vertical-align:top"><p>1</p></td><td style="vertical-align:top"><p>12</p></td><td style="vertical-align:top"><p>13</p></td></tr><tr><td style="vertical-align:top"><p>19.1 &ndash; 19.5</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>13</p></td><td style="vertical-align:top"><p>13</p></td></tr><tr><td style="vertical-align:top"><p>19.6 &ndash; 20.0</p></td><td style="vertical-align:top"><p>2</p></td><td style="vertical-align:top"><p>12</p></td><td style="vertical-align:top"><p>14</p></td></tr><tr><td style="vertical-align:top"><p>20.1 &ndash; 20.5</p></td><td style="vertical-align:top"><p>1</p></td><td style="vertical-align:top"><p>13</p></td><td style="vertical-align:top"><p>14</p></td></tr><tr><td style="vertical-align:top"><p>20.6 &ndash; 21.0</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>14</p></td><td style="vertical-align:top"><p>14</p></td></tr></tbody></table><p><sup>a</sup>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vial nominal concentration is 2&nbsp;&times;&nbsp;10<sup>13</sup>&nbsp;vg/mL and contains an extractable volume of not less than 5.5&nbsp;mL.</p><p><sup>b</sup>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vial nominal concentration is 2&nbsp;&times;&nbsp;10<sup>13</sup>&nbsp;vg/mL and contains an extractable volume of not less than 8.3&nbsp;mL.</p><p>&nbsp;</p><p>Not all pack sizes may be marketed in your country.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Receipt and thawing vials</u></p><p><u>&nbsp;</u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vials will be transported frozen (&le;&nbsp;‑60&ordm;C). Upon receipt vials should be refrigerated at 2&deg;C&nbsp;to&nbsp;8&deg;C immediately, and in the original carton. Onasemnogene abeparvovec therapy should be initiated within 14&nbsp;days of receipt of vials.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vials must be thawed before use. Do not use onasemnogene abeparvovec unless thawed.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For packaging configurations containing up to 9&nbsp;vials, product will be thawed after approximately 12&nbsp;hours in the refrigerator. For packaging configurations containing up to 14&nbsp;vials, product will be thawed after approximately 16&nbsp;hours in the refrigerator. Alternatively, and for immediate use, thawing may be performed at room temperature.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For packaging configurations containing up to 9&nbsp;vials, thawing will occur from frozen state after approximately 4&nbsp;hours at room temperature (20&deg;C&nbsp;to&nbsp;25&deg;C). For packaging configurations containing up to 14&nbsp;vials, thawing will occur from frozen state after approximately 6&nbsp;hours at room temperature (20&deg;C&nbsp;to&nbsp;25&deg;C)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Before drawing the dose volume into the syringe, gently swirl the thawed product. Do NOT shake.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use this medicine if you notice any particles or discolouration once the frozen product has thawed and prior to administration.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Once thawed, the medicinal product should not be re-frozen.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; After thawing, onasemnogene abeparvovec should be given as soon as possible. Once the dose volume is drawn into the syringe it must be infused within 8&nbsp;hours. Discard the vector‑containing syringe if not infused within the 8‑hour timeframe.</p><p>&nbsp;</p><p><u>Administration of onasemnogene abeparvovec to the patient</u></p><p><u>&nbsp;</u></p><p>To administer onasemnogene abeparvovec, draw the entire dose volume into the syringe. Remove any air in the syringe before intravenous infusion through a venous catheter.</p><p>&nbsp;</p><p><u>Precautions to be taken for the handling, disposal and accidental exposure to the medicinal product</u></p><p>&nbsp;</p><p>This medicinal product contains genetically-modified organisms. Appropriate precautions for the handling, disposal or accidental exposure of onasemnogene abeparvovec should be followed:</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The onasemnogene abeparvovec syringe should be handled aseptically under sterile conditions.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Personal protective equipment (to include gloves, safety goggles, laboratory coat and sleeves) should be worn while handling or administering onasemnogene abeparvovec. Personnel should not work with onasemnogene abeparvovec if skin is cut or scratched.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; All spills of onasemnogene abeparvovec must be wiped with absorbent gauze pad and the spill area must be disinfected using a bleach solution followed by alcohol wipes. All clean up materials must be double bagged and disposed of per local guidelines for handling of biological waste.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Any unused medicinal product or waste material should be disposed of in accordance with local guidelines on handling of biological waste.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; All materials that may have come in contact with onasemnogene abeparvovec (e.g. vial, all materials used for injection, including sterile drapes and needles) must be disposed of in accordance with local guidelines on handling of biological waste.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accidental exposure to onasemnogene abeparvovec must be avoided. In the event of exposure to skin, the affected area must be thoroughly cleaned with soap and water for at least 15&nbsp;minutes. In the event of exposure to eyes, the affected area must be thoroughly flushed with water for at least 15&nbsp;minutes.</p><p>&nbsp;</p><p><u>Shedding</u></p><p>&nbsp;</p><p>Temporary onasemnogene abeparvovec shedding may occur, primarily through bodily waste. Caregivers and patient families should be advised on the following instructions for the proper handling of patient bodily fluids and waste:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Good hand-hygiene (wearing protective gloves and washing hands thoroughly afterwards with soap and warm running water, or an alcohol-based hand sanitiser) is required when coming into direct contact with patient bodily fluids and waste for a minimum of 1&nbsp;month after onasemnogene abeparvovec treatment.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Disposable nappies should be sealed in double plastic bags and can be disposed of in household waste.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The Marketing Authorization Holder for this Product is Novartis Europharm Limited, Ireland.
www.Novartis.com

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                
	Approved by EMA in March 2024

            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>